List of Programs

Global Health

In today’s global economy, diseases have the potential to spread at warp speed. To protect the health of Americans and to address worldwide health threats, CDC is actively engaged in sharing knowledge and expertise in public health with international partners. The CDC Foundation helps CDC fight global health threats by fostering collaborations between CDC and other groups to support a variety of international health programs.

Global Health Programs

Aetiology of Neonatal Infection in South Asia

To characterize the pathogens that cause infections in young infants in developing countries - particularly Bangladesh, Pakistan and India - including a description of incidence, antimicrobial susceptibility and strain properties.

  • Funding Partners: Child Health Research Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Aetiology of Neonatal Infection in South Asia

AIDS and Kaposi’s Sarcoma in Uganda

To perform Human Herpesvirus-8 (HHV-8) diagnostics on specimens from a UCSF study on antiretroviral therapy for patients with AIDS and Kaposi’s sarcoma in Uganda.
  • Funding Partners: University of California San Francisco
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases

> AIDS and Kaposi’s Sarcoma in Uganda

Alternative Sanitation in Protracted Emergencies

To determine the safety and acceptability of urine-diversion toilets (UDTs) in refugee camps in Ethiopia in order to provide guidance on their use in humanitarian crises. By determining the environmental conditions necessary for maximum pathogen removal in a real setting, this will help improve existing and future UDT programs.

  • Funding Partners: Enhanced Learning and Research for Humanitarian Assistance
  • Program Partners: CDC’s Center for Global Health; Oxfam GB and United Nations High Commissioner for Refugees

> Alternative Sanitation in Protracted Emergencies

Atlanta International Health Fellowship Endowment

To provide funds for international participants to come to Atlanta to take part in public health courses at CDC or Emory University.

  • Funding Partners: Multiple individuals and organizations; Previous Partner: The Tull Charitable Foundation
  • Program Partners: CDC's Epidemic Intelligence Service; Emory University; Villa International

> Atlanta International Health Fellowship Endowment

Bed Nets for Children

To help CDC teams in Africa and Haiti purchase and distribute insecticide-treated bed nets to protect children and pregnant women from malaria.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Bed Nets for Children

Bloomberg Initiative to Reduce Tobacco Use

To create the Global Adult Tobacco Survey (GATS), a standard global surveillance system to monitor adult tobacco use and critical tobacco control measures, to inform, track and implement national and global programs and policies to reduce tobacco use.

  • Funding Partners: Bloomberg Philanthropies; Bill and Melinda Gates Foundation
  • Program Partners: CDC, World Health Organization

> Bloomberg Initiative to Reduce Tobacco Use

Bob Keegan Polio Eradication Heroes Fund

To recognize health care volunteers who have incurred serious injury or lost their lives as a direct consequence of their participation in polio eradication activities. The families of the workers, who have been the victims of automobile crashes, military conflicts and other life-threatening events, receive a certificate recognizing the victim's heroic commitment to polio eradication and a cash tribute.
  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Bob Keegan Polio Eradication Heroes Fund

CDC-Hubert Global Health Fellowship

To provide an opportunity for third- and fourth-year medical and veterinary students to gain public health experience in an international setting. Hubert fellows spend six to twelve weeks in a developing country working on a priority health problem in conjunction with CDC staff.

  • Funding Partners: O.C. Hubert Charitable Trust; Previous Partner: Pfizer Inc.
  • Program Partners: CDC's Office of Surveillance, Epidemiology and Laboratory Services

> CDC-Hubert Global Health Fellowship

Certified Water Quality Laboratory in Kenya

To make improvements to a water laboratory in Kenya that will enable it to be certified by the Ministry of Health. A certified laboratory would be authorized to become a regional reference laboratory that would provide needed services in the region such as water quality monitoring, outbreak response and research support.

  • Funding Partners: The P&G Fund of The Greater Cincinnati Foundation
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases, Division of Foodborne, and Environmental Diseases, Waterborne Disease Prevention Branch; Safe Water and AIDS Project (SWAP)

> Certified Water Quality Laboratory in Kenya

Cervical Cancer Screening and Treatment

To increase the availability of information on selected country programs—including readiness, opportunities and challenges—for implementation of surveillance, monitoring and evaluation of programs to screen and treat cervical cancer; and to develop a globally endorsed, standardized toolkit that can be adapted at the country level to support the collection of high-quality data for cervical cancer programs.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC’s Center for Global Health, Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, Sexual Transmitted Diseases and Tuberculosis Prevention, Epidemiology and Strategic Information Branch; CDC's Office of Noncommunicable Diseases, Injury and Environmental Health, National Center for Chronic Disease Prevention and Health Promotion, Division of Cancer Prevention and Control; George W. Bush Institute; World Health Organization

> Cervical Cancer Screening and Treatment

Chronic Hepatitis B Virus Infection in Tanzania

To implement and evaluate the feasibility of a care and treatment model for persons infected with chronic hepatitis B virus in resource-limited settings.
  • Funding Partners: Gilead Sciences
  • Program Partners: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Mnazi Mmoja Hospital; Muhimbili National Hospital

> Chronic Hepatitis B Virus Infection in Tanzania

Chronic Kidney Disease in Central American Workers

To investigate potential occupational causes of Chronic Kidney Disease in Central American countries.

  • Funding Partners: Los Azucareros del Istmo Centroamericano
  • Program Partners: CDC's Center for Global Health; CDC’s National Center for Environmental Health; Boston University School of Public Health

> Chronic Kidney Disease in Central American Workers

Compassion Fund for CDC's Global Health Workers

To provide financial relief to locally-employed CDC staff who are impacted by adverse conditions in the field. CDC employs more than 1,500 staff in 50+ countries around the world.
  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Compassion Fund for CDC's Global Health Workers

Controlling Mosquito Vectors of Malaria

To develop data that will contribute to an assessment of whether transgenic mosquitoes could be effectively and safely deployed to control natural populations of malaria vectors.

  • Funding Partners: Imperial College of London
  • Program Partners: CDC’s Center for Global Health; Bill & Melinda Gates Foundation

> Controlling Mosquito Vectors of Malaria

Cryptococcal Meningitis Screening in South Africa

To provide technical assistance to the monitoring and evaluation of a cryptococcal screening program in partnership with the South African government. Cryptococcal meningitis is a common infection and a leading cause of death among individuals with HIV/AIDS.

  • Funding Partners: Pfizer, Inc.
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases

> Cryptococcal Meningitis Screening in South Africa

Data for Health

To assist 20 low- and middle-income countries across Latin America, Asia and Africa in strengthening their public health data systems and data use for critical policy-making decisions.

  • Funding Partners: Bloomberg Philanthropies
  • Program Partners: CDC’s Center for Global Health; World Health Organization; Johns Hopkins Bloomberg School of Public Health; University of Melbourne; Vital Strategies (formerly The Union North America)

> Data for Health

Data to Action and Monitoring Tobacco Use in Asia

To build and enhance tobacco use surveillance and research capacity in Southeast Asia and China by expanding the Global Tobacco Surveillance System (GTSS). The GTSS will enable countries in the region to produce globally standardized tobacco use data and track key tobacco control measures among the region’s adult populations.

  • Funding Partners: Bill & Melinda Gates Foundation funded through the Bloomberg Philanthropies’ Bloomberg Initiative to Reduce Tobacco Use
  • Program Partners: World Health Organization; Johns Hopkins Bloomberg School of Public Health; Campaign for Tobacco Free Kids; The Union; Vital Strategies; RTI International; CDC National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Global Tobacco Control Branch

> Data to Action and Monitoring Tobacco Use in Asia

Development and Review of Logic Models

To enhance the quality of logic models used in program evaluation via a comprehensive checklist to guide development or review of logic models available at no-cost to users. 

  • Funding Partners: Faster Forward Fund
  • Program Partners: CDC’s Center for Global Health

> Development and Review of Logic Models

Emergency Obstetric Care in Tanzania

To improve access to quality emergency obstetric care and reduce maternal deaths in four pilot regions of Tanzania.

  • Funding Partners: Bloomberg Philanthropies
  • Program Partners: CDC’s Center for Global Health; National Center for Chronic Disease Prevention and Health Promotion; CDC - Tanzania

> Emergency Obstetric Care in Tanzania

Emerging Infectious Diseases in China

To enable a Pfizer Global Health Fellow to work alongside CDC scientists on assignment in China to improve prevention, detection and control of emerging infectious diseases.

  • Funding Partners: Pfizer, Inc.
  • Program Partners: CDC's Center for Global Health

> Emerging Infectious Diseases in China

Endowment for Global Health Priorities

To provide a source of flexible funding to CDC teams working in the field to meet critical or emergency needs that could not easily be met through usual government channels. Since it was created in 1999 by a group of CDC employees and retirees, the fund has provided resources for essential services and equipment such as bullet-proof vests for health workers vaccinating children in war-torn Somalia, ready-to-eat meals for workers in Sudan, satellite phones, incentives for vaccination campaigns in Mexico and India and training in other countries.
  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Endowment for Global Health Priorities

Evaluating Safe Water Interventions

To support CDC's work with international partners to develop and evaluate new tools and strategies to improve access to safe drinking water at a household level.
  • Funding Partners: The Clorox Company
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases

> Evaluating Safe Water Interventions

Evaluation of Cerus INTERCEPT System for Ebola

To evaluate the safety of Cerus Corporation’s Intercept Platform’s ability to inactivate the Ebola virus in human plasma.

  • Funding Partners: The Bill & Melinda Gates Foundation
  • Program Partners: CDC’s Center for Emerging and Zoonotic Infectious Diseases

> Evaluation of Cerus INTERCEPT System for Ebola

Evaluation of Malaria Specimen Bank

To analyze blood samples to determine what species of human malaria parasites are present in the specimens as part of an evaluation of a global malaria specimen bank.

  • Funding Partners: Foundation for Innovative New Diagnostics
  • Program Partners: CDC's Center for Global Health

> Evaluation of Malaria Specimen Bank

Evaluation of Rotavirus Vaccine in Vietnam

To establish rotavirus surveillance, implement rotavirus vaccination introduction and evaluate impact and effectiveness of rotavirus vaccination in targeted districts in Vietnam.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases; National Institute of Hygiene and Epidemiology

> Evaluation of Rotavirus Vaccine in Vietnam

Expanding the Immunization Data System in Nigeria

To overhaul the immunization data system at the National Health Care Development Agency of Nigeria. Expanding the information system will improve the accountability of the routine immunization program and provide the data for strategic planning and program implementation in Nigeria.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC’s Center for Global Health

> Expanding the Immunization Data System in Nigeria

Family Planning Project in Tanzania

To expand on an existing program to increase access to comprehensive emergency obstetric care (CEmOC) in Tanzania by integrating family planning (FP), comprehensive post-abortion care (CPAC) and family planning advocacy in ten health centers and add new health centers in Kigoma to be upgraded for the full package of CEmOC, FP and CPAC.
  • Funding Partners: Bloomberg Philanthropies
  • Program Partners: CDC's Center for Global Health; CDC’s National Center for Chronic Disease Prevention and Health Promotion; CDC – Tanzania

> Family Planning Project in Tanzania

Field Epidemiology Training Program - Saudi Arabia

To evaluate Saudi Arabia's infectious disease surveillance system, help train local and regional disease detectives and improve the country's capacity to monitor for and respond to infectious disease outbreaks.

  • Funding Partners: Kingdom of Saudi Arabia Ministry of Health
  • Program Partners: CDC's Center for Global Health

> Field Epidemiology Training Program - Saudi Arabia

Food Fortification Initiative

To promote the use of foods fortified with iron, zinc, calcium and folate around the world by encouraging the production and marketing of fortified flour and other products.

  • Funding Partners: Australian Department of Foreign Affairs and Trade; Bunge Limited; Global Alliance for Improved Nutrition (GAIN); Micronutrient Initiative; UNICEF; Cargill
  • Program Partners: CDC’s National Center for Chronic Disease Prevention and Health Promotion; Emory University; International Federation for Spina Bifida and Hydrocephalus

> Food Fortification Initiative

Gangarosa Endowment for Safe Water

To provide an ongoing source of support for CDC's safe water initiatives, Dr. Eugene Gangarosa and his wife, Rose, established the Gangarosa Endowment for Safe Water in May 2000, reflecting a lifelong commitment to provide safe water around the world.

  • Funding Partners: Gangarosa International Health Foundation, Inc.; multiple individuals and organizations
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Gangarosa Endowment for Safe Water

Global Monitoring of the Tobacco Epidemic

To create, launch and expand—as a component of the Bloomberg Initiative to Reduce Tobacco Use—a standard global surveillance system to monitor adult tobacco use and key tobacco control measures in countries with the highest burden from the tobacco epidemic. These data will be used to develop, implement and evaluate tobacco control policies and interventions that can reduce tobacco use at the national and global levels.

  • Funding Partners: Bloomberg Philanthropies
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Global Tobacco Control Branch; World Health Organization; Johns Hopkins Bloomberg School of Public Health; Campaign for Tobacco Free Kids; The Union; Vital Strategies; RTI International

> Global Monitoring of the Tobacco Epidemic

Global Rotavirus and IBVPD Reference Laboratories

To help CDC serve as a Global Reference Laboratory for the rotavirus and the invasive bacterial vaccine preventable diseases (IBVPD) laboratory networks, which provide support to the WHO-coordinated global rotavirus and the global IBVPD surveillance networks.
  • Funding Partners: World Health Organization
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Global Rotavirus and IBVPD Reference Laboratories

Global Rotavirus Reference Laboratory

To help CDC serve as a Global Reference Laboratory for the rotavirus laboratory network, which provides support to the global rotavirus surveillance network coordinated by the World Health Organization.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Global Rotavirus Reference Laboratory

Global VPIBD Reference Laboratory

To help CDC serve as a Global Reference Laboratory for the vaccine-preventable invasive bacterial diseases (VPIBD) laboratory network, which provides support to the global VPIBD surveillance network coordinated by the World Health Organization.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's Center for Global Health

> Global VPIBD Reference Laboratory

Health Care Providers Performance Review

To generate evidence-based recommendations via a systematic literature review on how to improve health care providers' performance in low-and middle-income countries.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC’s Center for Global Health

> Health Care Providers Performance Review

Impact Study of Rotavirus Vaccine in India

To generate data on the effectiveness and impact of rotavirus vaccination in early introducing regions of India and help establish a platform for assessment of safety with respect to intussusception.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunizations and Respiratory Disease

> Impact Study of Rotavirus Vaccine in India

Improving Hepatitis E Outbreak Control

To support a collaboration between CDC, the London School of Hygiene & Tropical Medicine and the United Nations Human Rights Council to partner on a joint proposal to the Research in Health for Humanitarian Crises to improve Hepatitis E outbreak control efforts among emergency affected populations.

  • Funding Partners: Enhancing Learning and Research for Humanitarian Assistance
  • Program Partners: CDC’s Center for Global Health; London School of Tropical Medicine; United Nations Human Rights Council

> Improving Hepatitis E Outbreak Control

Investigating Chronic Kidney Disease in Nicaragua

To facilitate collaboration and investigate the potential of non-occupational causes of chronic kidney disease in Nicaragua in connection with the Chronic Kidney Disease Research initiative in Central America.

  • Funding Partners: Comité Nacional de Productores de Azúcar
  • Program Partners: CDC’s Center for Global Health; CDC’s National Center for Environmental Health; Boston University School of Public Health

> Investigating Chronic Kidney Disease in Nicaragua

KSHV in Sub-Saharan Africa

To test blood and saliva samples from Uganda, Zimbabwe and South Africa for Kaposi sarcoma-associated herpesvirus (KSHV) antibodies and DNA; to measure KSHV seroprevalence and seroincidence; to analyze determinants of KSHV infection; and to examine the response of KSHV infection to antiretroviral therapy.
  • Funding Partners: University of California, San Francisco
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> KSHV in Sub-Saharan Africa

Labs for Life Fellowship

To support CDC’s Center for Global Health on a five-year public-private partnership between BD and PEPFAR focused on improving overall laboratory systems and services in Uganda, Ethiopia, Kenya, Mozambique and India, countries severely affected by HIV/AIDS and tuberculosis.
  • Funding Partners: BD (Becton, Dickinson and Company)
  • Program Partners: CDC's Center for Global Health; U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)

> Labs for Life Fellowship

Leveraging Rotavirus Networks

To determine the performance characteristics of tacrolimus-based (TAC) genotyping in comparison to conventional genotyping assays to better assess the role of different enteric pathogens in diarrhea requiring hospitalization among children less than five years of age. The technology will advance the analysis of rotavirus vaccine effectiveness studies by revealing how often cases of rotavirus vaccine failure are actually infections due to other enteric pathogens.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases; World Health Organization; University of Virginia

> Leveraging Rotavirus Networks

Louise Martin, D.V.M., M.S. EIS '85 Endowed Memorial Scholarship

When a terrorist bomb exploded at the American Embassy in Nairobi, Kenya on August 7, 1998, Mary Louise Martin was among the 12 Americans and more than 200 Kenyans killed. In her memory, friends and colleagues established the Louise Martin, D.V.M., M.S., EIS '85 Memorial Scholarship Endowment to provide scholarships for disadvantaged young women in Kenya to attend a national school.

  • Funding Partners: Battelle; Walter R. Dowdle, Ph.D., EIS Hon. '91; Taskforce for Global Health; multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Louise Martin, D.V.M., M.S. EIS '85 Endowed Memorial Scholarship

Malaria Host-Pathogen Interaction Center (MaHPIC)

To study and catalog in molecular detail how malaria parasites interact with their human and other animal hosts and cause disease using the “systems biology” approach. The project will integrate data generated by malaria research, functional genomics, proteomics, lipidomics and metabolomics cores, with the aid of informatics and computational modeling cores. CDC will be providing project support by generating proteomic data in the context of the project’s Proteomics Core and the Malaria Core.
  • Funding Partners: Emory University (National Institutes of Health)
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases and Center for Global Health; University of Georgia; Georgia Institute of Technology

> Malaria Host-Pathogen Interaction Center (MaHPIC)

Malaria in Pregnancy

To evaluate the impact of malaria on pregnancy outcomes in Latin American countries.

  • Funding Partners: Liverpool School of Tropical Medicine; Emory University
  • Program Partners: CDC's Center for Global Health

> Malaria in Pregnancy

Malaria Zero

To eliminate malaria in Haiti by 2020 by developing, adopting and implementing an evidence-based strategy and operational plan, securing resources, and improving and refining malaria surveillance systems in Hispaniola.

  • Funding Partners: Bill & Melinda Gates Foundation; multiple individual donors
  • Program Partners: CDC’s Center for Global Health; Ministry of Public Health and Population of Haiti; Ministry of Public Health and Social Assistance of the Dominican Republic; Pan American Health Organization; The Carter Center; Clinton Health Access Initiative; Tulane University School of Public Health and Tropical Medicine; London School of Hygiene & Tropical Medicine

> Malaria Zero

Maternal and Perinatal Death Surveillance

To reduce maternal and perinatal death globally through strengthening implementation of Maternal and Perinatal Death Surveillance and Response (MPDSR) systems and advise WHO and partners on guidance, standards of practice and tools to help achieve the post-MDG maternal and newborn goals and targets.
  • Funding Partners: World Health Organization
  • Program Partners: CDC’s National Center for Chronic Disease Prevention and Health Promotion

> Maternal and Perinatal Death Surveillance

MenAfriNet Meningitis Surveillance in Africa

To establish a regional surveillance network—MenAfriNet—to collect and analyze high quality case-based meningitis surveillance data from representative sites across the African meningitis belt. The meningitis surveillance network will evaluate the impact of MenAfriVac to guide research on new vaccines and strategies to optimize impact of existing vaccines.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases; WHO-AFRO; Agence de Medicine Preventive; Ministries of Health and other non-governmental agencies

> MenAfriNet Meningitis Surveillance in Africa

Meningitis Carriage Study in Burkina Faso

To conduct an evaluation of N. Meningitidis and N. Lactamica in Burkina Faso as part of a larger initiative to introduce a novel serogroup A conjugate meningococcal vaccine in Africa and eliminate epidemic meningitis.
  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases; Norwegian Institute of Public Health

> Meningitis Carriage Study in Burkina Faso

Mortality Surveillance in Acute Emergencies

To establish new collaborations and strengthen partnerships between CDC, Save the Children Foundation in the United States, Save the Children Foundation International, UN agencies and other major humanitarian partners for the purpose of implementing and evaluating two community-based methods of mortality data collection.

  • Funding Partners: Save the Children
  • Program Partners: CDC’s Center for Global Health; United Nations High Commissioner for Refugees

> Mortality Surveillance in Acute Emergencies

Pneumococcal Disease in Qatar

To evaluate the impact of Pneumococcal Conjugate Vaccine (PCV-13) on vaccine and non-vaccine serotypes causing both invasive and non-invasive diseases in Qatar. The study also assesses the overall prevalence and serotype distribution of S.pneumoniae nasopharyngeal carriage in both healthy and sick children below five years of age over a three-year period.

  • Funding Partners: Hamad Medical Corporation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Pneumococcal Disease in Qatar

Pneumococcal Evolution and Vaccine Effectiveness

To help CDC contribute to research about genetic changes in pneumococcal bacteria that impact the effectiveness of vaccination in developing countries. CDC will provide isolates from their Global Pneumococcal Strain Bank, sequence isolates from the Active Bacterial Core surveillance collaboration, and provide expert guidance on analysis and interpretation of the data.
  • Funding Partners: Emory University (Gates Foundation)
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases

> Pneumococcal Evolution and Vaccine Effectiveness

Pneumococcal Vaccine Effectiveness in HIV-Infected Children

To estimate the effectiveness of two or more doses of 13-valent pneumococcal conjugate vaccine (PCV-13) against laboratory-confirmed vaccine-serotype invasive pneumococcal disease (IPD) (13 serotypes in the vaccine) among HIV-infected and HIV-uninfected children eligible to receive vaccination through the routine vaccination program in South Africa, compared to no vaccination.

  • Funding Partners: PATH
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Pneumococcal Vaccine Effectiveness in HIV-Infected Children

Pneumonia Etiology Research for Child Health

To establish a case control study of severe acute lower respiratory infections in children under age 5 in Thailand to determine the etiology and risk factors associated with pneumonia.

  • Funding Partners: Johns Hopkins Bloomberg School of Public Health (Bill & Melinda Gates Foundation)
  • Program Partners: CDC’s Center for Global Health; CDC - Thailand

> Pneumonia Etiology Research for Child Health

Polio Antivirals and Strain-specific Immunity

To accelerate development of polio antiviral compounds in support of the Polio Antivirals Initiative and to support studies of strain-specific immunity to polio genotypes currently circulating in India.
  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Polio Antivirals and Strain-specific Immunity

Preventing Maternal Deaths in Tanzania

To focus on improving family planning and maternal health in Tanzania’s Kigoma region in the third phase of this project, involving CDC, the World Lung Foundation and Engender Health.

  • Funding Partners: Bloomberg Philanthropies; Fondation H & B Agerup
  • Program Partners: CDC’s National Center for Chronic Disease Prevention and Health Promotion; CDC’s National Center for Global Health

> Preventing Maternal Deaths in Tanzania

Primate Retroviral Transmission

To track the transmission of blood-borne microbes between non-human primates and domestic animals living near Kibale National Park, Uganda.

  • Funding Partners: University of Wisconsin (National Institutes of Health)
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Primate Retroviral Transmission

Protective Immunity to Norovirus in Indian Cohort

To establish the role of norovirus as a cause of diarrheal disease and to understand the development of protective immunity in a birth cohort in India.

  • Funding Partners: Christian Medical College, Vellore (Bill & Melinda Gates Foundation)
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases

> Protective Immunity to Norovirus in Indian Cohort

Rapid Diagnostic Tests for Malaria Elimination

To support the development of improved rapid diagnostic tests for malaria elimination making available panels of cultured parasites for product development and validation.
  • Funding Partners: Foundation for Innovative New Diagnostics
  • Program Partners: CDC’s Center for Global Health

> Rapid Diagnostic Tests for Malaria Elimination

Reducing HIV Acquisition through PrEP - Uganda

To assess, through clinical trials in Uganda, the safety and efficacy of pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine/tenofovir in reducing HIV acquisition.

  • Funding Partners: University of Washington
  • Program Partners: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; The AIDS Support Organization-Mbale and Tororo, Uganda

> Reducing HIV Acquisition through PrEP - Uganda

Road Traffic Injury Prevention and Control in India

To work closely with partners in India to develop, implement, evaluate and disseminate evidence-based interventions to address the critical issue of occupational and non-occupational road safety and trauma care and to promote road traffic injury prevention.

 

  • Funding Partners: Conrad N. Hilton Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Road Traffic Injury Prevention and Control in India

Rotavirus Breast Milk Analysis

To collect breast milk in mothers with infants less than 6 months of age in developing and developed countries in order to maximize levels of antibody response to rotavirus and compare the inhibitory effect of maternal antibodies on vaccine strains.

  • Funding Partners: Emory National Science & Technology Council; Glaxo SmithKline Biologicals s.a.
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus Breast Milk Analysis

Rotavirus Intussusception Surveillance in South Africa

To initiate a network of South African hospitals to conduct intussusception surveillance and apply the resource-efficient and scientifically sound case-series analysis to generate vital evidence for monitoring the safety of rotavirus vaccine use.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases; University of Witwatersrand

> Rotavirus Intussusception Surveillance in South Africa

Rotavirus Surveillance

To allow countries, primarily in Asia and Africa, to continue rotavirus surveillance activities in anticipation of the introduction of the rotavirus vaccine.

  • Funding Partners: GlaxoSmithKline Biologicals s.a.; Merck Sharp & Dohme Corp.
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus Surveillance

Rotavirus Surveillance in Ghana and Rwanda

To determine, following the introduction of the rotavirus vaccine in Ghana and Rwanda, the impact of the vaccine on rotavirus cases and on diarrhea morbidity from all causes.

  • Funding Partners: PATH
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Rotavirus Surveillance in Ghana and Rwanda

Safe Delivery for Mothers in Kenya

To help CDC and its partners in rural western Kenya provide transportation to a healthcare facility for expecting mothers and ensure that women giving birth in a facility or at home have access to a safe delivery kit and blood supply.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC's Center for Global Health

> Safe Delivery for Mothers in Kenya

Stephen B. Thacker Fund

To honor Dr. Thacker's life and service to public health as well as his passion for the Epidemic Intelligence Service. Established by the Thacker Family through the CDC Foundation.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC's Office of Surveillance, Epidemiology and Laboratory Services

> Stephen B. Thacker Fund

Strengthening Disease Surveillance and Response in Central Africa

To strengthen disease surveillance and response programs in select Central African countries.

  • Funding Partners: The Bill & Melinda Gates Foundation
  • Program Partners: CDC's Center for Global Health; CDC's National Center for Immunization and Respiratory Diseases; World Health Organization

> Strengthening Disease Surveillance and Response in Central Africa

Strengthening Disease Surveillance in West Africa

To provide applied epidemiology training to public health officials from the ministries of health of the French-speaking member states that constitute the Economic Community of West African States.

  • Funding Partners: West African Health Organisation (International Bank for Reconstruction and Development)
  • Program Partners: CDC’s Center for Global Health

> Strengthening Disease Surveillance in West Africa

Strengthening Global Emergency Management

To fortify elements critical to global health security—public health infrastructure and country capacity—to ensure rapid detection and response of public health threats in the West Africa region.

  • Funding Partners: CDC’s National Center for Global Health (cooperative agreement from CDC)
  • Program Partners: CDC’s National Center for Global Health

> Strengthening Global Emergency Management

Strengthening Laboratory Quality in Kazakhstan

To assist the Ministry of Health of the Republic of Kazakhstan in developing quality control mechanisms and a state-of-the-art laboratory quality management system model. The project will strengthen laboratory quality assurance systems and help set up a National Reference Laboratory and four expert laboratories to serve as methodological and educational centers for laboratory networks and build capacity for laboratory staff, managers and decision makers.

  • Funding Partners: Ministry of Public Health of the Republic of Kazakhstan (International Bank for Reconstruction and Development)
  • Program Partners: CDC’s Center for Global Health

> Strengthening Laboratory Quality in Kazakhstan

Supporting Water & Hygiene in Mali

To provide both rapid and sustainable access to water to an estimated 66,000 people in healthcare facilities in marginalized, rural, trachoma-endemic communities in Mali.
  • Funding Partners: WaterAid America
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases

> Supporting Water & Hygiene in Mali

Tobacco Control Surveillance and Capacity Building in Africa

To build and enhance tobacco use surveillance and research capacity in sub-Saharan Africa by expanding the Global Tobacco Surveillance System (GTSS). The GTSS will enable sub-Saharan African countries to produce globally standardized tobacco use data and track key tobacco control measures among the region’s adult and youth populations.

  • Funding Partners: The Bill & Melinda Gates Foundation
  • Program Partners: CDC’s National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Global Tobacco Control Branch; World Health Organization; RTI International

> Tobacco Control Surveillance and Capacity Building in Africa

Vaccine Induced Immune Responses to Plasmodial Antigens

To support an immunization and chade Beaumontllenge trial of CDC's P. falciparum chimeric MSP1/8 vaccine in nonhuman primates. The specific model will involve studies in the monkey species Aotus nancymaae using the P. falciparum FVO strain.

  • Funding Partners: Dexel University
  • Program Partners: CDC’s Center for Global Health

> Vaccine Induced Immune Responses to Plasmodial Antigens

Vector Stock and Reagent Repository for Research

To maintain, produce, authenticate and distribute arthropod vectors and associated reagents for the Microbiology and Infectious Diseases Biological Research Resources (MID-BRR) Program.
  • Funding Partners: American Type Culture Collection; (NIH/National Institute of Allergy and Infectious Diseases)
  • Program Partners: CDC's Center for Global Health

> Vector Stock and Reagent Repository for Research

Viral Hepatitis in Resource-Limited Countries

To develop an action plan and framework to guide the treatment and testing of viral hepatitis in resource-limited countries. CDC’s Division of Viral Hepatitis and the World Health Organization will work directly with ministries of health in key countries to expand capacity and establish and implement effective strategies around viral hepatitis control.
  • Funding Partners: Gilead Sciences, Inc.
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Viral Hepatitis in Resource-Limited Countries

Water Quality Testing in Low-Resource Settings

To develop the evidence base for use of the Compartment Bag Test, a portable water quality test that determines if drinking water contains E. coli bacteria and poses a health risk. This study will provide international public health organizations scientifically-backed guidance on use of the test in low-resource settings and during emergency response.

  • Funding Partners: Conrad N. Hilton Foundation
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Water Quality Testing in Low-Resource Settings

Chronic Disease & Birth Defects

Heart disease, cancer, diabetes, childhood asthma, obesity and other chronic conditions that affect us — and those we care about — now account for 70 percent of all deaths in the United States. Racial, ethnic and socioeconomic health disparities persist and widen. While CDC is best-known for fighting infectious disease outbreaks, CDC also provides the science that helps community leaders, employers and families battle chronic health threats by choosing and promoting healthy behaviors. The CDC Foundation helps connect CDC with foundations and businesses in the private sector that have a shared interest in promoting healthy life styles and preventing chronic diseases.

Chronic Disease & Birth Defects Programs

"Healthbound" Policy Simulation Game

To support CDC’s development and promotion of a web-based policy simulation game that helps users explore the likely consequences of changing one or more aspects of the US health system.

  • Funding Partners: Analytic Services, Inc.
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion; Applied Systems Thinking Institute

> "Healthbound" Policy Simulation Game

500 Cities Project

To promote chronic disease prevention and health promotion for the 500 largest American cities by identifying, analyzing and reporting census tract-level data through an interactive City Health Indicator website.

  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> 500 Cities Project

Biomarker Detection of Cervical Cancer

To help CDC participate in research to evaluate the use of the magnetic microfluidic chip to improve detection of cervical cancer.

  • Funding Partners: University of Georgia
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Biomarker Detection of Cervical Cancer

Biomarkers of Infertility

To study biomarkers of infertility in 750 women trying to conceive over 12 months. CDC will perform a sample analysis and advise on the study design, sample collection and data analyses, measuring FSH and the estrogen metabolite, estrone 3-glucuronide, for standardized pregnancy determination.

  • Funding Partners: University of North Carolina at Chapel Hill (National Institutes of Health)
  • Program Partners: CDC's National Center on Birth Defects and Developmental Disabilities

> Biomarkers of Infertility

Contraceptive Use Module for States

To support state use of a module on the Behavioral Risk Factor Surveillance System that assesses contraceptive use among women aged 50 and younger. This effort will allow for the development of state-level estimates of the methods of contraception used and reasons for not using contraception.
  • Funding Partners: Guttmacher Institute
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Contraceptive Use Module for States

Evaluation of Program Impact Through PRAMS

To facilitate a collaboration between CDC and the W.K. Kellogg Foundation to assess the potential impact of Kellogg-supported interventions through the use of CDC's Pregnancy Risk Assessment Monitoring System (PRAMS). PRAMS collects state-specific, population-based data on maternal attitudes and experiences before, during, and shortly after pregnancy.

  • Funding Partners: W.K. Kellogg Foundation
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Evaluation of Program Impact Through PRAMS

Health Consequences of Marijuana

To develop a comprehensive, in-depth systematic review of existing evidence regarding health consequences of marijuana use, as well as to identify a short- and long-term research agenda focused on improving our understanding of the potential association of marijuana use with acute and chronic health outcomes. Additionally, the project will include a variety of activities to ensure broad dissemination and use of the report findings by key stakeholders in public health, healthcare and public policy.

  • Funding Partners: Mat-Su Health Foundation; The Truth Initiative; Colorado Health Foundation; Robert W. Woodruff Foundation; Alaska Mental Health Trust Authority; California Department of Public Health
  • Program Partners: CDC's Office of Noncommunicable Disease, Injury and Environmental Health

> Health Consequences of Marijuana

Healthy People 2020 Law and Health Policy Project

To develop progress reports linked to Healthy People 2020 (a science-based, 10-year national objective for improving the health of Americans) to demonstrate the value of legal and policy interventions in improving Americans' health.

  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Healthy People 2020 Law and Health Policy Project

Heart Disease and Stroke Prevention Campaign

To develop a national cardiovascular prevention campaign in alliance with the Million Hearts® initiative and the Division for Heart Disease and Stroke Prevention to encourage more Americans to engage with their healthcare providers to address the “ABCs” of heart health and identify lifestyle behaviors that could increase the risk of cardiovascular disease and stroke.

  • Funding Partners: Pfizer Inc.
  • Program Partners: CDC’s National Center for Chronic Disease Prevention and Health Promotion

> Heart Disease and Stroke Prevention Campaign

Hormone Laboratory Collaborations

To help CDC provide reference and quality control materials for laboratory collaboration, including collaborations for the Hormone Measurement Standardization program.

  • Funding Partners: AB SCIEX; Abbott Laboratories; American University of Beirut; Ann & Robert H. Lurie Children's Hospital of Chicago; ARUP Laboratories; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; BMH Holdings (TMS BioScience Labs); Covance; DiaSorin Inc.; DIAsource Immunoassays; Douglass Hanly Moir Pathology; Endoceutics, Inc.; Euroimmun Medizinische Labordiagnostika AG; Fujirebio Diagnostics, Inc; Fujirebio Inc.; Health Canada; Immunodiagnostic Systems Inc.; Immunotech S.A.S. (Beckman Coulter, Inc); Laboratory Corporation of America Holdings; Los Angeles Biomedical Research Institute; Microgenics Corporation (Thermo Fisher Scientific, Inc.); New England Research Institutes, Inc.; Harvard University (Partners HealthCare System, Inc.); Pathology Associates Medical Laboratories; Quest Diagnostics; Reprosource Fertility Diagnostics; Roche Diagnostics Corporation; Sahlgrenska University Hospital; Siemens; Social & Scientific Systems, Inc.; Tosoh Bioscience, Inc.; Tricore Reference Laboratories; University College Cork; University of Helsinki; VU University Medical Center Amsterdam; ZRT Laboratory; multiple donors
  • Program Partners: CDC's Division of Laboratory Sciences

> Hormone Laboratory Collaborations

Improving Health Outcomes of LGBT Youth

To address critical gaps in knowledge about protective factors and interventions that promote positive health outcomes among lesbian, gay, bisexual and transgender (LGBT) youth, and to possibly improve academic and social outcomes in this population. This project will result in the development and dissemination of publications and other resources that enhance the scientific and programmatic response to HIV, STDs and other sexual health issues among LGBT youth.

  • Funding Partners: Arcus Foundation
  • Program Partners: CDC’s National Center for Chronic Disease Prevention and Health Promotion

> Improving Health Outcomes of LGBT Youth

Laboratory Surveillance for Factor XIII Deficiency

To provide support for Factor XIII testing to accurately diagnose patients in the United States in order to enhance the surveillance of rare bleeding disorders.

  • Funding Partners: Novo Nordisk Inc.
  • Program Partners: CDC’s National Center on Birth Defects and Developmental Disabilities

> Laboratory Surveillance for Factor XIII Deficiency

Maternal Mortality Review Data System

To increase the United States’ capacity to use data for preventing maternal mortality.

  • Funding Partners: Merck for Mothers
  • Program Partners: CDC's National Center on Birth Defects and Developmental Disabilities

> Maternal Mortality Review Data System

Newborn Screening Test for Spinal Muscular Atrophy

To facilitate collaborative development of a newborn bloodspot screening test to detect the genetic lesions that cause spinal muscular atrophy. The test will be designed to use in public health newborn screening laboratories.

  • Funding Partners: Biogen
  • Program Partners: CDC’s Division of Laboratory Sciences

> Newborn Screening Test for Spinal Muscular Atrophy

Newborn Screening Translation Research Initiative

To improve four major areas of newborn screening: 1) developing new screening methods for specific diseases, 2) integrating state public health laboratories in the translation process through collaborative field studies, 3) expanding the global reach of newborn screening, and 4) adapting innovative technologies for screening and quality assurance.

  • Funding Partners: Genzyme Corporation
  • Program Partners: CDC’s National Center for Environmental Health; California Department of Health Services; Emory University; Jeffrey Modell Foundation; Kennedy Krieger Institute; Medical College of Georgia; New York State Department of Health; The Johns Hopkins Bloomberg School of Public Health; The University of Texas at San Antonio; University of Washington; Washington State Department of Health; Wisconsin State Laboratory of Hygiene; Association of Public Health Laboratories; Illinois Department of Public Health; Georgia Public Health Laboratory; University of California San Francisco; New England Newborn Screening Program; University of Pittsburgh Medical Center Mayo Clinic

> Newborn Screening Translation Research Initiative

Paul M. Fernhoff Memorial Lecture Series

To host an educational and inspirational lecture that continues the legacy of Dr. Paul Fernhoff who shepherded the development of Georgia’s newborn screening program, which now monitors every baby born in Georgia for more than 50 genetic disorders. The lecture series will enhance the visibility and expand the potential benefits of newborn screening.

  • Funding Partners: The Legacy of Angels Foundation
  • Program Partners: CDC’s Division of Laboratory Sciences

> Paul M. Fernhoff Memorial Lecture Series

Planes, Trains and Auto-mobility

To increase walking in the Atlanta Hartsfield-Jackson International Airport using motivational signage to encourage passengers to walk from the terminal to their concourse rather than ride the airport train.

  • Funding Partners: The Kresge Foundation
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Planes, Trains and Auto-mobility

Preconception Health Mobile Application

To develop a preconception health mobile application that will serve as one of the intervention components of the national “Show Your Love” campaign developed by the Preconception Health and Health Care Initiative. The campaign is designed to improve the health of women and babies by promoting preconception health and healthcare.  

  • Funding Partners: Anthem, Inc.
  • Program Partners: CDC's National Center on Birth Defects and Developmental Disabilities

> Preconception Health Mobile Application

Preventing Mother-to-Child Transmission of HIV and HBV

To help CDC increase understanding of the effectiveness of using maternal tenofovir containing combination drug during the second and third trimesters of pregnancy for the prevention of mother-to-child transmission of HIV and HBV in co-infected mothers.

  • Funding Partners: Gilead Sciences, Inc.
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Preventing Mother-to-Child Transmission of HIV and HBV

Screening of Congenital Adrenal Hyperplasia

To determine the impact of molecular testing on newborn screening for Congenital Adrenal Hyperplasia (CAH). The goal of the project is to improve clinical outcomes by early detection and treatment of infants affected by CAH and to reduce the burden of false positives on families and providers. 

  • Funding Partners: University of Minnesota (National Institutes of Health)
  • Program Partners: CDC's Division of Laboratory Sciences

> Screening of Congenital Adrenal Hyperplasia

Sickle Cell Data Collection (SCDC) Program

To build the framework for collecting data about individuals in the United States with sickle cell disease in order to monitor their health outcomes, evaluate current systems of care, and inform the development of a comprehensive care model to meet the needs of these individuals throughout their life.

  • Funding Partners: Biogen; Pfizer Inc.
  • Program Partners: CDC’s National Center on Birth Defects and Developmental Disabilities

> Sickle Cell Data Collection (SCDC) Program

Study of Blood Inhibitors in Hemophilia Patients

To monitor hemophilia patients for the development of inhibitors and establish a surveillance system to collect and analyze a uniform set of clinical data.

  • Funding Partners: Pfizer Inc.; Wyeth Pharmaceuticals; Previous Partners: Baxter International, Inc.
  • Program Partners: CDC's National Center on Birth Defects & Developmental Disabilities

> Study of Blood Inhibitors in Hemophilia Patients

Tackling Hunger to Improve Health in Americans

To identify and disseminate effective strategies to address the cycle of food insecurity and its relationship to acute medical events in people with chronic diseases.

  • Funding Partners: ProMedica; AARP Foundation
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion

> Tackling Hunger to Improve Health in Americans

Testing of Sexual Identity Questions by CDC's National Center for Health Statistics

To develop and field test questions on sexual identity for inclusion in the National Health Interview Study.

  • Funding Partners: Gill Foundation
  • Program Partners: CDC's National Center for Health Statistics

> Testing of Sexual Identity Questions by CDC's National Center for Health Statistics

Infectious Disease

Many infections, once though conquered, have reemerged in drug-resistant forms. Globalization — from air travel to food production — has opened new doors for bacteria and viruses to enter the U.S. One of CDC's most visible roles is identifying and controlling outbreaks of infectious diseases and protecting us from emerging infectious threats. The CDC Foundation provides opportunities for outside partners to support CDC's efforts and join in the fight.

Infectious Disease Programs

Analysis of the Global Burden of Norovirus

To implement a landscape analysis and hold a consultative meeting focused on gathering current data on the global burden of norovirus disease and the epidemiology of norovirus infections. The outcome will include a white paper on the current burden of norovirus and vaccine prospects.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Analysis of the Global Burden of Norovirus

Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

To support the Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C (BEST-C), a multi-year study that will evaluate the effectiveness of screening all persons born from 1945 to 1965 for Hepatitis C (HCV) in order to increase the proportion of people who are aware of their HCV status.

  • Funding Partners: AbbVie, Inc.; Previous Partners: Genentech, A Member of the Roche Group; Merck Sharp & Dohme; Janssen Pharmaceutical Companies of Johnson & Johnson; Vertex Pharmaceuticals
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

Childhood Immunization Champions Award Fund

To recognize individuals in each U.S. state who make a significant contribution toward improving public health through their work in childhood immunization.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases

> Childhood Immunization Champions Award Fund

Chronic Hepatitis B and C Cohort Study

To establish the first comprehensive U.S. longitudinal observational cohort of 15,000 or more patients with chronic viral hepatitis B and C in order to improve understanding of chronic viral hepatitis and the impact of screening, care and treatment recommendations.

  • Funding Partners: AbbVie, Inc.; Janssen Global Services; Gilead Sciences, Inc.; Previous Partners: Vertex Pharmaceuticals; Bristol-Myers Squibb; Abbott Laboratories; Johnson & Johnson; Genentech
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Chronic Hepatitis B and C Cohort Study

Clinical Trials Unit for HIV/AIDS and TB Research

To facilitate formation of a Clinical Trials Unit for HIV/AIDS and tuberculosis research to advance therapy and prevention. If the interventions in the clinical trials are determined safe and effective, they will add to the options available to prevent and control these diseases of global significance.

  • Funding Partners: Emory University (National Institutes of Health)
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Clinical Trials Unit for HIV/AIDS and TB Research

Combination HIV Prevention Intervention in Thailand

To conduct a study to assess the feasibility of a combination HIV preventive intervention with and without daily Truvada PrEP for HIV uninfected young men who have sex with men in Bangkok, Thailand.

  • Funding Partners: Johns Hopkins University (National Institutes of Health/National Institute of Allergy and Infectious Disease)
  • Program Partners: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of HIV/AIDS Prevention; Thailand Ministry of Public Health

> Combination HIV Prevention Intervention in Thailand

Controlling Viral Foodborne Disease

To help CDC collaborate with the U.S. Department of Agriculture and the National Institute of Food and Agriculture to create an integrated, multi-disciplinary approach to developing improved tools, skills and capacity to study foodborne viruses. Outcomes of the partnership will be used to systematically identify risk factors and develop risk management strategies to reduce contamination in pre- and post-harvest environments.
  • Funding Partners: North Carolina State University; United States Department of Agriculture
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Controlling Viral Foodborne Disease

Crimean-Congo Hemorrhagic Fever Study

To research the nairovirus, Crimean-Congo hemorrhagic fever, a tick-borne viral disease, especially common in East and West Africa. With mortality rates as high as 80 percent and with no FDA approved vaccines or therapeutics, Crimean-Congo hemorrhagic fever is considered a dangerous pathogen and a serious bioterrorism threat. The project will expand the knowledge of the ovarian tumor protease domain of the nairovirus to inform control measures and vaccine development.

  • Funding Partners: University of Georgia (National Institutes of Health)
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Crimean-Congo Hemorrhagic Fever Study

David J. Sencer CDC Museum AIDS History Project

To document CDC’s role during the early years of the AIDS epidemic by gathering information and documents from CDC scientists, public health advisors and other staff who worked during the early years of the epidemic.

  • Funding Partners: Abbott Laboratories; Gilead Sciences
  • Program Partners: CDC’s Office of the Associate Director for Communication; Emory University

> David J. Sencer CDC Museum AIDS History Project

Electronic Health Records For Hepatitis C Testing

To develop clinical quality improvement infrastructure for Hepatitis C screening and referral to treatment.

  • Funding Partners: Gilead Sciences
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Electronic Health Records For Hepatitis C Testing

Evaluation of Rabies Virus Vectored Ebola Vaccine

To design and evaluate a thermostable Rabies Virus Vectored Ebola Vaccine. As Ebola exists in some of the poorest parts of the world where the climate is tropical, the development of a thermostable vaccine could be cost-effective, resulting in greater long-term vaccine stability in high ambient temperatures.

  • Funding Partners: Thomas Jefferson University (National Institutes of Health)
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Evaluation of Rabies Virus Vectored Ebola Vaccine

Expanding Community Participation in SaludBoricua

To promote community participation in SaludBoricua, the Puerto Rico participatory surveillance program for acute febrile illnesses, which include dengue, influenza, leptospirosis and chikungunya. A mobile app will be developed to capture data and a media campaign launched to encourage participation.
  • Funding Partners: Skoll Global Threats Fund
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Expanding Community Participation in SaludBoricua

Genomic Epidemiology of Neisseria Gonorrhoeae

To study demographic data and Neisseria gonorrhoeae isolates collected as part of the Gonococcal Isolate Surveillance Project and to look at within-host diversity in an ongoing study of extra- genital gonococcal infection.

  • Funding Partners: Brigham and Women's Hospital (Partners HealthCare System, Inc.)
  • Program Partners: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Genomic Epidemiology of Neisseria Gonorrhoeae

Global Burden of Foodborne Norovirus

To estimate incidence rates of gastroenteritis due to norovirus by age and country/WHO region, taking; to describe and quantify the available data on health effects resulting from these infections; to estimate the proportion of norovirus that is foodborne; and to provide a critical appraisal of data gaps.

  • Funding Partners: World Health Organization
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Global Burden of Foodborne Norovirus

Griffithsin-based Rectal Microbicides Study

To evaluate the effectiveness of the Griffithsin gel treatment.

  • Funding Partners: University of Louisville; University of Louisville Research Foundation (National Institutes of Health)
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

> Griffithsin-based Rectal Microbicides Study

Group B Streptococcus Vaccine Development

To provide technical assistance to WHO's Initiative for Vaccine Research (IVR) to further group B streptococcus (GBS) vaccine development for low and middle income countries that cannot implement intrapartum antibiotic prophylaxis.

  • Funding Partners: World Health Organization (Bill & Melinda Gates Foundation)
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Group B Streptococcus Vaccine Development

Hand Hygiene Education in U.S. Healthcare Settings

To improve hand hygiene outreach in U.S. healthcare facilities by providing hand hygiene educational materials and tools for patients, healthcare providers and caregivers in U.S. healthcare facilities such as hospitals, nursing homes and other ambulatory care locations.

  • Funding Partners: GOJO Industries
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Hand Hygiene Education in U.S. Healthcare Settings

Healthy Swimming in the United States

To conduct research and raise awareness about preventing recreational water illness associated with the use of treated public water venues such as pools, hot tubs and water parks.

  • Funding Partners: National Swimming Pool Foundation; ESSRX; Lupin Pharmaceuticals; Previous Partners: American Chemistry Council; Chem-Aquascience, Inc.; Lonza Group, Ltd (Arch Chemicals, Inc.); NSPF for CMAHC; Slack, Inc.
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Healthy Swimming in the United States

Hepatitis C Testing Stakeholder Panels

To conduct stakeholder panels with the goal of supporting the implementation of CDC’s Hepatitis C testing recommendations for individuals born from 1945-1965.

  • Funding Partners: Abbvie
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Hepatitis C Testing Stakeholder Panels

Improving Pneumococcal Vaccine

To compare the immunogenicity of current vaccines for pneumococcal disease (native pneumococcal polysaccharide vaccine) with a proposed new vaccination method (microsphere entrapped pneumococcal capsular polysaccharides delivered either subcutaneously or intranasally).

  • Funding Partners: Georgia Research Alliance
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases; Emory University; Mercer University

> Improving Pneumococcal Vaccine

Increasing the Supply of Organs for Georgians

To increase the number of organs that are used for transplant in Georgia and the U.S. by using advanced analytics methods for quantifying the risk and comparing survival of receiving a transplant versus remaining on the wait list, and embed these methods into easy-to-use multilingual decision support tools to assist doctors and patients in their decision-making. Overall, this research will lead to a comprehensive plan for increasing organ transplants and saving lives in Georgia and across the country.
  • Funding Partners: Georgia Tech (Carlos and Marguerite Mason Trust)
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Increasing the Supply of Organs for Georgians

Integrated Rotavirus Vaccine Development Plan

To implement a robust product development program for an integrated inactivated rotavirus vaccine in low-income countries.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Integrated Rotavirus Vaccine Development Plan

Leveraging Data for Hepatitis C Surveillance

To strengthen surveillance for hepatitis C (HCV) infection by using commercial lab data to obtain, analyze and disseminate data on HCV testing. This project will complete an analysis of non-invasive markers for liver fibrosis in the dataset to estimate the stage of liver disease for persons newly positive for HCV.

  • Funding Partners: Abbvie
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Leveraging Data for Hepatitis C Surveillance

Making Dialysis Safer for Patients

To reduce potentially deadly bloodstream infections in hemodialysis outpatients by targeting patients, healthcare providers and caregivers using evidence-based communications strategies with prevention messages.

  • Funding Partners: Amgen
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Making Dialysis Safer for Patients

Malaria Research and Reference Reagent Repository

To support a mosquito stock repository that supplies living and preserved laboratory cultured malaria-vector mosquitoes to researchers studying malaria.

  • Funding Partners: American Type Culture Collection (National Institutes of Health)
  • Program Partners: CDC's National Center for Preparedness, Detection, and Control of Infectious Diseases

> Malaria Research and Reference Reagent Repository

Microbicide Intrauterine System for HIV Prevention

To perform preclinical research targeted towards HIV prevention in women.

  • Funding Partners: CONRAD (Eastern Virginia Medical School)
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Microbicide Intrauterine System for HIV Prevention

Microbicide to Prevent HIV Transmission

To support the development of a safe and effective microbicide to serve as a pre-exposure prophylaxis against the transmission of HIV.
  • Funding Partners: ImQuest BioSciences, Inc.
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Microbicide to Prevent HIV Transmission

Monitoring Malaria Treatment in the U.S.

To collect, manage and analyze data on the safety and efficacy of artemether/lumefantrien used to treat cases of malaria in the U.S.

  • Funding Partners: Novartis Pharmaceuticals Corporation
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Monitoring Malaria Treatment in the U.S.

Multistate Fungal Meningitis Outbreak Management

To respond to an unprecedented outbreak of central nervous system, joint and osseous mold infections that have been observed, beginning in August of 2012, among hundreds of patients who received contaminated methylprednisolone injections. This project will collect long-term follow-up data on diagnosis and appropriate treatment of fungal meningitis and other fungal infections associated with this outbreak in order to fully understand and track the burden of these infections.

  • Funding Partners: Springer Science+Business Media LLC
  • Program Partners: CDC’s National Center for Emerging and Infectious Zoonotic Diseases

> Multistate Fungal Meningitis Outbreak Management

Norovirus and Gastroenteritis Surveillance

To expand surveillance of norovirus infection and acute gastroenteritis in a managed-care population to better understand incidence, seasonal patterns, clinical characteristics and the epidemiological profile of the diseases and inform prevention efforts.
  • Funding Partners: Takeda Pharmaceutical Company
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Norovirus and Gastroenteritis Surveillance

Norovirus In-Vitro Time-Kill Evaluation

To evaluate commercial sanitizing products for their virucidal effectiveness against murine norovirus.

  • Funding Partners: Applied Biocode; Cepheid; Luminex Corporation; Nanosphere, Inc.; R-Biopharm, Inc.; Previous Partners: Arch Chemicals, Inc.; Byotrol; Clemson University; GOJO Industries, Inc.; Holland America Line; IISES, LLC; International Atomic Energy Agency; LigoCyte Pharmaceuticals; Molnlycke Health Care, LLC; Oxoid Ltd.; Pathcon Laboratories; Proctor & Gamble Company; Radco Chemical Solution; Remel, Inc.; Takeda Pharmaceuticals; University of Queensland; Therapeutic Goods; University of North Carolina
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Norovirus In-Vitro Time-Kill Evaluation

Opt-Out Chlamydia Screening Effectiveness

To explore the effectiveness of opt-out chlamydia screening via electronic health record prompt and to increase the percentage of women under the age of 25 who are screened for chlamydia at clinical encounters.

  • Funding Partners: Hologic, Inc.
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; University of Pittsburgh

> Opt-Out Chlamydia Screening Effectiveness

Partnership Fund for HPV Genotyping

To provide technical and analytical expertise in HPV genotyping and immune response measurements to academic and other partners in need of these assays to advance public health objectives related to HPV vaccine impact monitoring and HPV epidemiology.

  • Funding Partners: ViroStat, Inc.
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Partnership Fund for HPV Genotyping

Patient Tools for Antibiotic Stewardship Programs

To develop a data collection and analysis tool to assess outcomes of Antimicrobial Stewardship Programs.
  • Funding Partners: Merck (formerly Cubist Pharmaceuticals)
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Patient Tools for Antibiotic Stewardship Programs

PET-C: HCV in Opiate Agonist Treatment Settings

To evaluate the acceptance and utility of telemedicine as a method to deliver hepatitis C virus (HCV) management to patients, with the addition of education, prevention, and awareness efforts as a multi-pronged treatment approach among patients on methadone maintenance.

  • Funding Partners: AbbVie, Inc.; Vertex Pharmaceuticals, Inc.; Previous Partners: Abbott
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> PET-C: HCV in Opiate Agonist Treatment Settings

Point-of-Care Diagnostics for Norovirus

To help CDC collaborate in a larger norovirus study by developing glycan-based assays to evaluate a panel of different synthetic glycans as well as naïve norovirus stool strains.

  • Funding Partners: Georgia State University (National Institutes of Health)
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Point-of-Care Diagnostics for Norovirus

Prevent Antimicrobial Resistance in Healthcare Setting

To develop a series of health communications aimed at increasing awareness among physicians of CDC's goals of preventing the spread of antimicrobial resistance. The goal of this initiative is to develop an integrated program to prevent emergence and spread of antimicrobial-resistant infections among patients in healthcare settings.

  • Funding Partners: BD (Beckton, Dickinson and Company); Cubist Pharmaceuticals (now Merck); Kimberly-Clark USA; Merck Sharp & Dohme Corp.; Ortho-McNeil Pharmaceutical, Inc.; Premier, Inc.; University of Alabama at Birmingham; Vermont Oxford Network, Inc.; Wellpoint Foundation
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Prevent Antimicrobial Resistance in Healthcare Setting

Preventing Infections in Cancer Patients

To develop a comprehensive education campaign targeting cancer patients, their families and their providers to reduce the risk of infection in multiple settings (outpatient office, hospital and home).
  • Funding Partners: Amgen
  • Program Partners: CDC's National Center for Chronic Disease Prevention and Health Promotion; CDC’s National Center for Emerging and Zoonotic Infectious Diseases; Medscape; WebMD Health Corporation

> Preventing Infections in Cancer Patients

Production of Rabies Virus Antigens in Rice

To help CDC collaborate in the development of a new rice-based rabies vaccine that has the potential to be safer and less expensive than current oral rabies vaccines.

  • Funding Partners: Ventria Biosciences, Inc.
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Production of Rabies Virus Antigens in Rice

Rift Valley Fever Virus Vaccination Development

To assist in the development of novel vaccines and comprehensive strategies for the prevention of Rift Valley Fever virus in both livestock and humans using recombinant proteins and 96-well ELISA or Luminex platforms to detect anti-NP, anti-NSs or anti-NSm antibodies.
  • Funding Partners: Texas A&M University
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases

> Rift Valley Fever Virus Vaccination Development

Safe Injection Practices Coalition

To promote safe injection practices in all U.S. healthcare settings, the Safe Injection Practices Coalition is a partnership of healthcare-related organizations, patient advocacy organizations, industry partners and other public health partners, led by CDC. The Coalition has developed the One & Only Campaign—a public health education and awareness campaign—aimed at both healthcare providers and patients to advance and promote safe injection practices.

  • Funding Partners: Eli Lilly and Company
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases; Accreditation Association for Ambulatory Health Care, Inc. (AAAHC); American Association of Nurse Anesthetists (AANA); Association for Professionals in Infection Control and Epidemiology, Inc. (APIC); American Society for Healthcare Risk Management (ASHRM); Association of State and Territorial Health Officials (ASTHO); Eli Lilly and Company; HONOReform Foundation; Institute for Safe Medication Practices (ISMP); National Association of County & City Health Officials (NACCHO); Premier Safety Institute; Society of Gastroenterology Nurses and Associates (SGNA); The Society for Healthcare Epidemiology of America (SHEA); U.S. Food and Drug Administration – Safe Use Initiative (Advisor)

> Safe Injection Practices Coalition

Sixth International Calicivirus Conference

To support the travel, accommodation and participation of researchers from low- income and middle-income countries to attend the 2016 International Calicivirus Conference.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC's National Center for Immunization and Respiratory Diseases

> Sixth International Calicivirus Conference

Study of Dapivirine Gel Administered Rectally

To study the effectiveness of dapivirine gel exposure intended to prevent HIV transmission.

  • Funding Partners: Magee-Womens Research Institute and Foundation (National Institutes of Health/National Institute of Allergy and Infectious Disease)
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Division of HIV/AIDS Prevention; Thailand Ministry of Public Health

> Study of Dapivirine Gel Administered Rectally

Sustainable Health Center Implementation PrEP Pilot (SHIPP) Study

To learn lessons about how best to incorporate the delivery of daily oral pre-exposure prophylaxis (PrEP) into the services provided by health centers serving sexually active adults at high risk of acquiring HIV infection. The pilot study will initiate data collection at federally-qualified health centers (FQHCs) or look-alikes in four U.S. cities.
  • Funding Partners: Gilead Sciences, Inc.
  • Program Partners: CDC’s National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Central Care Community Health Center; Strawberry Mansion Health Center; Access Community Health Network – Grand Boulevard Clinic; Newark Community Health Centers, Inc.; University of Colorado

> Sustainable Health Center Implementation PrEP Pilot (SHIPP) Study

Synthesis of XMRV Peptides

To develop a mass spectrometry method that can be used to identify and quantify a novel protein produced by the prostate-cancer-associated retrovirus XMRV in patient samples.
  • Funding Partners: Edinburgh Napier University; Emory University School of Medicine; Lypro Biosciences, Inc.; The Children’s Hospital of Philadelphia; University of Maryland Baltimore (National Institutes of Health); University of Louisville; Global Blood Therapeutics
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infections

> Synthesis of XMRV Peptides

TB Clinical Research Database and Drug Monitoring

To abstract data from medical records of tuberculosis patients to study modeling the pharmacokinetics of second-line anti-tuberculosis drugs.
  • Funding Partners: University of Florida (Bill & Melinda Gates Foundation)
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> TB Clinical Research Database and Drug Monitoring

Teens Linked to Care

To provide substance use and HIV prevention education, access to health services, safe and supportive environments and monitoring and evaluation for high-risk communities in Kentucky, Ohio and Indiana.

  • Funding Partners: Conrad Hilton Foundation
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Teens Linked to Care

The Sally Schieffelin Potter Endowment for Healthcare-Associated Infections

To provide support to CDC, working toward the elimination of healthcare-associated infections in all medical care settings.

  • Funding Partners: Multiple individuals and organizations; Previous Partner: The Sally Schieffein Potter Endowment
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> The Sally Schieffelin Potter Endowment for Healthcare-Associated Infections

Travelers Health Educational Activities - Yellow Book

To promote safety and wellness among U.S. travelers through the collection and dissemination of up-to-date and accurate scientific information.

  • Funding Partners: Multiple organizations
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Travelers Health Educational Activities - Yellow Book

Treatment of TB with Priftin (rifapentine)

To continue the research and development of the drug Priftin® (rifapentine) and to investigate its role in the treatment of active tuberculosis (TB) disease and latent TB infection.
  • Funding Partners: Sanofi Foundation for North America
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Treatment of TB with Priftin (rifapentine)

Typhoid Vaccine Protocol Development

To develop a standardized protocol that developing country vaccine manufacturers may use for evaluating Vi enzyme-linked immunosorbent assays and reference standards to support product registration.

  • Funding Partners: Bill & Melinda Gates Foundation
  • Program Partners: CDC’s National Center for Environmental Health

> Typhoid Vaccine Protocol Development

Understanding Antibiotic Use Data

To gain a comprehensive understanding of antibiotic use in inpatient and outpatient healthcare settings in the United States.

  • Funding Partners: The Pew Charitable Trusts
  • Program Partners: CDC's National Center for Emerging and Zoonotic Infectious Diseases

> Understanding Antibiotic Use Data

Viral Hepatitis Action Coalition

To provide an overall framework for organizations concerned with viral hepatitis to support high priority research, education and program evaluation projects initiated by CDC's Division of Viral Hepatitis.

  • Funding Partners: Abbott Laboratories; AbbVie; Bristol-Myers Squibb; Gilead Sciences, Inc.; Janssen Therapeutics; Merck Sharp & Dohme; OraSure Technologies; Quest Diagnostics; Siemens Healthcare Diagnostics; Previous Partners: Alere North American, Inc.; Bayer Corporation; Boehringer Ingelheim; Genentech; Gen-Prob, Inc.; GlaxoSmithKline; Kadmon Pharmaceuticals; Onyx Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc.
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention; Association of State and Territorial Health Officials (ASTHO); National Viral Hepatitis Roundtable

> Viral Hepatitis Action Coalition

Word-of-Mouth Travel Health Education Programs

To improve acceptance of pre-travel vaccines, medicines and preventive behaviors among high-risk travelers through evaluation of the outcome of a word-of-mouth travel health education program among Asian Indians in New York, New Jersey and Connecticut.

  • Funding Partners: GlaxoSmithKline
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases, Division of Global Migration and Quarantine, Travelers' Health Branch; HealthTalker

> Word-of-Mouth Travel Health Education Programs

Youth HIV/STD Prevention Campaign

To implement a HIV/STD prevention campaign for youth and gay, bisexual and transgender (GBT) youth.

  • Funding Partners: MAC AIDS Fund
  • Program Partners: CDC's National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention

> Youth HIV/STD Prevention Campaign

Injury & Violence

Preventable injury and violence are leading causes of death and disability. On one end of the spectrum, homicide is the second leading cause of death among young people between the ages of 10 and 24 years old. At the other end, falls are the leading cause of injury deaths and emergency room visits for seniors. CDC works to prevent unintentional injuries – from car crashes to senior falls – as well as injuries and death resulting from violence. The CDC Foundation helps connect CDC to outside partners that share CDC's goals of reducing injury- and violence-related death and disability through prevention.

Injury & Violence Programs

Adaptation of Evidence-based Interventions in Violence Prevention

To help CDC study how community-based organizations adapt evidence-based interventions and whether or not those adaptations make the programs more or less effective. The initial study will focus on violence prevention programs, but researchers at CDC believe the outcomes of the research will be relevant to other public health issues and programs.

  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Adaptation of Evidence-based Interventions in Violence Prevention

Early Childhood and Health Inequities Engagement and Awareness Campaign

To support the dissemination of The Raising of America, a documentary series and multimedia initiative that reframes the way we look at early child health and development. This two-year national public engagement and education initiative aims to prevent child maltreatment and achieve health equity by improving social and economic conditions for all children and their families.

  • Funding Partners: Doris Duke Charitable Foundation
  • Program Partners: CDC’s National Center for Injury Prevention and Control

> Early Childhood and Health Inequities Engagement and Awareness Campaign

Evaluation of UPS’s Road Code Teen Driving Program

To conduct a program analysis and evaluation of United Parcel Service’s (UPS) Road Code, an interactive program that brings UPS's safe driving techniques and methods to teenage drivers. CDC will conduct an analysis of the UPS Road Code curriculum, provide recommendations and resources based on the most recent and best available science and provide in-depth consultation on and assistance with the evaluation of the UPS Road Code program.

  • Funding Partners: The UPS Foundation
  • Program Partners: CDC’s National Center for Injury Prevention and Control

> Evaluation of UPS’s Road Code Teen Driving Program

Gun Violence Prevention Advisory Committee Research Agenda

To develop a research agenda to address the causes and prevention of gun violence. To meet this goal, CDC is requesting the Institute of Medicine, through the National Academy of Sciences (NAS) and in collaboration with the National Research Council, to appoint an advisory committee to develop the proposed research agenda, using established NAS procedures. The proposed agenda will identify the most critical research questions that can be answered in the short-term (3-5 years) to improve knowledge of the following: 1) causes of gun violence; 2) interventions that prevent gun violence; and 3) strategies to minimize the public health burden of gun violence.
  • Funding Partners: Kaiser Permanente; The Joyce Foundation; The Annie E. Casey Foundation; The California Endowment; The California Wellness Foundation; GE Foundation; Robert Wood Johnson Foundation; Conway Santol; Krezel
  • Program Partners: CDC’s National Center for Injury Prevention and Control, National Academy of Sciences

> Gun Violence Prevention Advisory Committee Research Agenda

Monitoring and Evaluating “Head Safe, Helmet On”

To provide technical assistance with the monitoring and evaluation of the U.S. Agency for International Development (USAID) program “Head Safe, Helmet On,” which promotes safety and the use of helmets for drivers, passengers and children in targeted provinces in Cambodia.

  • Funding Partners: AIP Foundation; Asia India Prevention
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Monitoring and Evaluating “Head Safe, Helmet On”

Optimizing Helmets to Reduce Work-Related Injuries

To optimize helmet design to reduce the severity of head injuries at construction worksites. The study will build on CDC’s research of digital human modeling of personal protective equipment and will respond to construction industry-wide needs for effective assessment methods to control exposures resulting in fatal and nonfatal work-related traumatic brain injury.

  • Funding Partners: Turner Construction Company; Liberty Mutual Insurance; Zurich American Insurance Company; ACE Construction Group
  • Program Partners: CDC’s National Institute for Occupational Safety and Health; West Virginia University’s Department of Neurosurgery; International Safety Equipment Association

> Optimizing Helmets to Reduce Work-Related Injuries

Piloting the Cardiff Model for Violence Prevention

To facilitate implementation of the Cardiff Model for Violence Prevention in two sites in the United States—Philadelphia, PA, and metropolitan Atlanta, GA. The purpose of the pilot is to document the strengths, challenges and costs of the program and to determine technical needs. The prevention strategies implemented in the pilot will help guide future evaluation research and implementation of the model in the United States.

  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Piloting the Cardiff Model for Violence Prevention

Positive Parenting Program

To help CDC's Division of Violence Prevention launch the Positive Parenting Program (Triple P) model through partnerships between Federally Qualified Health Centers and local public health agencies.

  • Funding Partners: Doris Duke Charitable Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Positive Parenting Program

Together for Girls

To enable CDC to work with individual countries and regions to quantify the problem of sexual violence against girls and subsequently develop evidence-based policies and programs to protect children and prevent violence.

  • Funding Partners: BD (Becton, Dickinson and Company); Henry Shein Cares Foundation; Nduna Foundation; multiple individual donors
  • Program Partners: CDC’s National Center for Injury Prevention and Control; UN Women; UNAIDS; United Nations Population Fund; UNICEF; USAID; World Health Organization; Pan American Health Organization; Grupo ABC; BD (Becton, Dickinson and Company); Nduna Foundation

> Together for Girls

Violence Against Children Survey for Domestic Use

To assess the possibility of adapting the global Violence Against Children Survey for use in the United States and identifying funding partners.
  • Funding Partners: Robert Wood Johnson Foundation
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Violence Against Children Survey for Domestic Use

Environmental Health

The places where people live, work and play can greatly impact their health. CDC conducts research that analyzes to what extent these possible environmental threats affect our health and who may be most at risk. The CDC Foundation helps CDC collaborate with universities and research institutions in the U.S. and around the world to investigate potential environmental health threats and make recommendations for how to mitigate their affects on our health.

Environmental Health Programs

Acrylamide Exposure and Risk of Endometrial and Ovarian Cancer

To assess exposure to acrylamide in a subset of the European Prospective Investigation into Cancer and Nutrition (EPIC) study cohort and assess possible associations between acrylamide exposure and endometrial and ovarian cancers.

  • Funding Partners: Bellvitge Biomedical Research Institute (IDIBELL)
  • Program Partners: CDC’s National Center for Environmental Health

> Acrylamide Exposure and Risk of Endometrial and Ovarian Cancer

Adipose Deposition of Environmental Toxins

To determine which of the selected environmental chemicals detected in blood in the NHANES survey by CDC can be detected and measured in the serum and urine tissue, as well as the change over time in the detected environmental toxin levels in the blood and urine of patients who undergo bariatric surgery and experience significant weight loss.

  • Funding Partners: Johns Hopkins Bloomberg School of Public Health
  • Program Partners: CDC’s National Center for Environmental Health

> Adipose Deposition of Environmental Toxins

Antimicrobial Chemicals in Allergic Disease

To investigate whether exposure to the antimicrobial phenols (e.g., triclosan and parabens) increases the risk of developing allergen sensitization and clinical allergic disease via inducing dysbiosis of the human microbiota.

  • Funding Partners: Brigham and Women's Hospital Div of Rheumatology, Immunology and Allergy (Partners HealthCare System, Inc.): Previous Partners: Harvard University (Partners HealthCare System, Inc.)
  • Program Partners: CDC’s National Center for Environmental Health

> Antimicrobial Chemicals in Allergic Disease

Antimicrobials: The Microbiome and Gene Expression

To perform interventional trials on the use of triclosan and non-triclosan containing products and determine the effects of triclosan use on the microbiome and on gene expression.

  • Funding Partners: Brigham and Women's Hospital, Partners HealthCare System, Inc. (National Institutes of Health)
  • Program Partners: CDC’s National Center for Environmental Health

> Antimicrobials: The Microbiome and Gene Expression

Asthma and Secondhand Smoking

To quantify exposure to secondhand smoke by measuring levels of nicotine metabolites and then assess the relationship between secondhand smoke exposure and the development of asthma and allergy in children.

  • Funding Partners: Simon Fraser University
  • Program Partners: CDC's National Center for Environmental Health

> Asthma and Secondhand Smoking

Bisphenol A Exposure and Gestational Diabetes Risk

To measure urinary concentrations of environmental phenols to assess whether exposure to environmental chemicals such as Bisphenol A is associated with an increased risk of Gestational Diabetes.
  • Funding Partners: University of Cincinnati, College of Medicine
  • Program Partners: CDC’s National Center for Environmental Health

> Bisphenol A Exposure and Gestational Diabetes Risk

Caffeine Consumption Validation Study

To investigate the validity of a 24-hour caffeine recall survey.
  • Funding Partners: University of Waterloo, Canada
  • Program Partners: CDC’s National Center for Environmental Health

> Caffeine Consumption Validation Study

Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) Environmental Study

To examine the association of exposure to phthalates with health outcomes in child development using samples collected from participants of the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) study. CDC’s Organic Analytical Toxicology Branch will measure the urinary concentrations of phthalate metabolites in urine collected from CHAMACOS participants. Approximately 700 samples will be analyzed for phthalate metabolites.

  • Funding Partners: University of California Berkeley (National Institutes of Health)
  • Program Partners: CDC’s National Center for Environmental Health

> Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) Environmental Study

Chemicals and Exosomal miRNAs in Ovarian Follicles

To evaluate the association between exposure to endocrine disputing chemicals and fertility by measuring microRNA (miRNA) profiles in follicular fluidisolated exosomes with oocyte maturation and day three embryo quality.
  • Funding Partners: Harvard Chan School of Public Health
  • Program Partners: CDC’s National Center for Environmental Health

> Chemicals and Exosomal miRNAs in Ovarian Follicles

Child Development and Exposure to Phthalates and BPA

To assess the effects of exposure to phthalates and bisphenol A (BPA) on the fetal and pubertal development of children.

  • Funding Partners: Harvard Medical School Channing Laboratory (National Institute of Environmental Health Sciences / National Institutes of Health and the Environmental Protection Agency); Previous Partners: University of Illinois at Urbana-Champaign; Harvard Medical School (National Institute of Environmental Health Sciences); Partners Health System
  • Program Partners: CDC’s National Center for Environmental Health

> Child Development and Exposure to Phthalates and BPA

Effects of Carcinogens from High Fat Diets

To investigate the potential effect of exposure to BP-3 in mice on susceptibility to mammary tumor development and interaction with a diet high in animal fat.
  • Funding Partners: Michigan State University (National Institutes for Health)
  • Program Partners: CDC’s National Center for Environmental Health

> Effects of Carcinogens from High Fat Diets

Effects of Chemicals on Child Development

To explore the potential impact during gestation of maternal exposure to personal care products on physical and neurological developmental characteristics of the infants during their first years of life.

  • Funding Partners: University of Illinois College of Veterinary Medicine (National Institute of Environmental Health Sciences)
  • Program Partners: CDC’s National Center for Environmental Health

> Effects of Chemicals on Child Development

Effects of Organic Diet on Pesticides Exposure

To evaluate the effects of a maternal organic diet on exposure to pesticides during pregnancy.
  • Funding Partners: Boise State University
  • Program Partners: CDC’s National Center for Environmental Health

> Effects of Organic Diet on Pesticides Exposure

Effects of Perfluoroalkyls on Stroke and Mortality

To investigate the association between exposure to polyfluorinated chemicals (PFCs) and the risk of stroke, as an ancillary project of the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
  • Funding Partners: West Virginia University
  • Program Partners: CDC’s National Center for Environmental Health

> Effects of Perfluoroalkyls on Stroke and Mortality

Endocrine Disruptors & Male Reproductive System

To study the influence of prenatal exposure to phthalates and BPA on the occurrence of genital abnormalities in the French general population.
  • Funding Partners: National Institute of Health and Medical Research, France INSERM
  • Program Partners: CDC’s Center for Environmental Health

> Endocrine Disruptors & Male Reproductive System

Endocrine Disruptors and Uterine Fibroids

To evaluate exposure to phthalates, polychlorinated biphenyls (PCB) and bisphenol A (BPA) in relation to incident uterine leiomyomata (UL) in an established cohort of women from Study of Environment Lifestyle and Fibroids (SELF).
  • Funding Partners: Boston University
  • Program Partners: CDC’s National Center for Environmental Health

> Endocrine Disruptors and Uterine Fibroids

Endocrine Disruptors Exposure and Prenatal Risk

To examine whether maternal exposure to endocrine disrupting chemicals (e.g., phenols, phthalates) affect maternal the ribonucleic acid profile as well as ribonucleic acid, proteins and hormonal levels and whether in-utero and early life outcomes differ between males and female twins in the same twin pair.
  • Funding Partners: Sheba Medical Center and Tel Aviv University
  • Program Partners: CDC’s National Center for Environmental Health

> Endocrine Disruptors Exposure and Prenatal Risk

Endocrine Disruptors: Prenatal Epigenetics

To investigate the potential association between prenatal exposure to endocrine disruptors and the development of adiposity-related outcomes in the offspring.
  • Funding Partners: University of Colorado
  • Program Partners: CDC’s National Center for Environmental Health

> Endocrine Disruptors: Prenatal Epigenetics

Environmental Exposure and ALS

To measure the levels of gamma-tocopherols, 25-hydroxyvitamine, pesticides and blood lead and study their association with the development of Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease).

  • Funding Partners: Emory University
  • Program Partners: CDC's National Center for Environmental Health

> Environmental Exposure and ALS

Exposure to Antibacterial Compounds

To examine whether exposure to certain antibacterial chemicals is implicated in allergic and respiratory diseases through alteration of the human microbiome.
  • Funding Partners: University of Bergen
  • Program Partners: CDC’s National Center for Environmental Health

> Exposure to Antibacterial Compounds

Exposure to Endocrine Disruptors and Breast Cancer Risk

To measure phthalate metabolites and phenols to help determine their potential role in breast cancer development.
  • Funding Partners: Mount Sinai School of Medicine (National Institutes of Health)
  • Program Partners: CDC’s National Center for Environmental Health

> Exposure to Endocrine Disruptors and Breast Cancer Risk

Fibroids Research on Genes and Environment

To evaluate the role of environmental exposures by race/ethnicity, and to investigate the potential association between exposure to environmental chemicals and the risk of developing uterine leiomyomas.

  • Funding Partners: Milken Institute School of Public Health at The George Washington University
  • Program Partners: CDC’s National Center for Environmental Health

> Fibroids Research on Genes and Environment

Flame Retardants and Flight Attendant Health

To assess the exposure to flame retardants and polyfluorinated compounds (PFCs) in flight attendants and evaluate the association between serum levels of flame retardants and PFCs and thyroid hormone disruption.
  • Funding Partners: Harvard University
  • Program Partners: CDC’s National Center for Environmental Health

> Flame Retardants and Flight Attendant Health

Folate Status in the U.K. Population

To determine folate status across the U.K. in order to establish a population baseline should mandatory folic acid fortification proceed.
  • Funding Partners: Human Nutrition Research at the Medical Research Council
  • Program Partners: CDC's National Center for Environmental Health

> Folate Status in the U.K. Population

Ghana Pilot Study-Early Pesticides Exposure

To quantify exposure to pyrethroids and organophosphate pesticides in pregnant women and children in rural Ghana.
  • Funding Partners: Massachusetts General Hospital (Partners Healthcare System)
  • Program Partners: CDC’s National Center for Environmental Health

> Ghana Pilot Study-Early Pesticides Exposure

Health Outcomes and Measures of the Environment

To analyze data through the Health Outcomes and Measures of the Environment (HOME) study, a prospective birth cohort of mothers and their children from Cincinnati, Ohio, who have been followed from the second trimester of pregnancy until the child is around 8 years old. A thousand human serum and 74 milk samples will be analyzed for persistent organic pollutants (POPs) and serum lipids, and measurements of polyfluoroalkyl chemicals (PFCs) in approximate 800 serum samples will be taken. The data will be essential to showing the levels of serum of POPs and PFCs in the HOME cohort at age 1, 2, 3 and 5 years of age.

  • Funding Partners: Brown University School of Public Health; Previous Partners: University of Cincinnati College of Medicine; Simon Fraser University
  • Program Partners: CDC’s National Center for Environmental Health

> Health Outcomes and Measures of the Environment

High Fat Diet and Oxybenzone in Breast Cancer Risk

To investigate the potential association between high fat diet and benzophenone as risk factors for breast cancer.
  • Funding Partners: Michigan State University
  • Program Partners: CDC’s National Center for Environmental Health

> High Fat Diet and Oxybenzone in Breast Cancer Risk

Hyperuricemia in American Indian Families

To study the effect of environmental pollutants in American Indians in an effort to investigate their effect on hyperuricemia by themselves or in interaction with genetic factors.
  • Funding Partners: University of North Carolina at Chapel Hill
  • Program Partners: CDC’s National Center for Environmental Health

> Hyperuricemia in American Indian Families

Impact of Environmental Exposures in Children

To investigate the potential impact of exposure to environmental chemicals on neurodevelopmental outcomes in children with congenital heart defects.

  • Funding Partners: Children’s Hospital of Philadelphia
  • Program Partners: CDC’s National Center for Environmental Health

> Impact of Environmental Exposures in Children

Impact of Flame Retardant Exposure on Children

To measure serum levels of polybrominated diphenyl ethers (PBDE), polychlorinated biphenyls (PCBs) and pesticides in 850 children at birth, at 2 to 3 and 5 to 7 years of age. This study will characterize the longitudinal impact of PBDE exposure, commonly known as flame retardant, occurring throughout childhood on neurodevelopment.

  • Funding Partners: Columbia University, New York
  • Program Partners: CDC’s National Center for Environmental Health

> Impact of Flame Retardant Exposure on Children

Impact of Pesticide Exposure in Child Development

To investigate whether neurotoxicant exposure during pregnancy affects the development of children during the first four years of their lives.

  • Funding Partners: Scientific Research Center, Suriname
  • Program Partners: CDC’s National Center for Environmental Health

> Impact of Pesticide Exposure in Child Development

Infant Feeding, Early Development and Isoflavones

To measure approximately 50 infant and toddler urine specimens for phytoestrogens as part of an observational, longitudinal, prospective cohort study with the Children’s Hospital of Philadelphia. The study will investigate hormonal endpoints during infancy and toddlerhood in relation to feeding by breast milk, cow-milk based formula or soy-protein based formula.

  • Funding Partners: Harvard Department of Environmental Health: Previous Partners: National Institute of Environmental Health Sciences; Social & Scientific Systems, Inc.
  • Program Partners: CDC’s National Center for Environmental Health; Harvard University

> Infant Feeding, Early Development and Isoflavones

Investigating Chlorine Dioxide as Disinfectant

To evaluate the use of chlorine dioxide as a disinfectant in recreational water venues.

  • Funding Partners: National Swimming Pool Foundation
  • Program Partners: CDC’s National Center for Emerging and Zoonotic Infectious Diseases

> Investigating Chlorine Dioxide as Disinfectant

Maternal Organics Monitoring Study

To collect and analyze biological (blood, cord, urine) samples from 200 Alaska Native mother-infant pairs over the period of one year. The levels of persistent organic pollutants, heavy metals, cytokines, selenium and a fatty acid profile in pregnant women and newborn infants will be measured, as will levels of radioactive isotopes, phthalate, mercury, arsenic, polycyclic aromatic hydrocarbons and phytoestrogensin.

  • Funding Partners: Alaska Native Tribal Health Consortium
  • Program Partners: CDC’s National Center for Environmental Health

> Maternal Organics Monitoring Study

Microbiome in Pregnancy and Infancy

To characterize environmental exposures experienced by pregnant women and their infant children and their association with the developing human intestinal microbiome. Concentrations of triclosan and parabens will be measured in urines collected from pregnant women who participated in the Lifecodes study and their infants.

  • Funding Partners: Brigham and Women's Hospital Div of Rheumatology, Immunology and Allergy (Partners HealthCare System, Inc.): Partner: Harvard University Medical School (Partners Healthcare System)
  • Program Partners: CDC’s National Center for Environmental Health

> Microbiome in Pregnancy and Infancy

Nutritional Biomarkers Control Materials Testing

To perform characterization measurements on multiple aliquots of biological matrices to ensure the accuracy of nutritional biomarkers in controlled blood samples.
  • Funding Partners: Craft Technologies Inc.
  • Program Partners: CDC’s National Center for Environmental Health

> Nutritional Biomarkers Control Materials Testing

Organophosphate Pesticides in Rural Communities

To evaluate the impact of educational intervention on organophosphate exposure and risk perception of parents and schoolchildren from two school communities in the Maule region, Chile.
  • Funding Partners: Catholic University of Maule
  • Program Partners: CDC’s National Center for Environmental Health

> Organophosphate Pesticides in Rural Communities

PAHs Exposure Assessment in Disadvantaged Areas

To demonstrate that a passive wristband sampler can be used to quantify personalized exposure to environmental chemicals such as polycyclic aromatic hydrocarbons (PAHs) with higher compliance and equal accuracy compared to an active air sampler, and to show the utility of a mobile phone-enabled application to concurrently capture lung function measurements.
  • Funding Partners: Columbia University Mailman School of Public Health
  • Program Partners: CDC’s National Center for Environmental Health

> PAHs Exposure Assessment in Disadvantaged Areas

PCBs, Phthalates and Male Reproductive Health

To determine if and how exposure to PCBs and phthalates affects male fertility.

  • Funding Partners: Harvard University, School of Public Health Channing Division; Previous Partner: Harvard University, School of Public Health
  • Program Partners: CDC's National Center for Environmental Health

> PCBs, Phthalates and Male Reproductive Health

Perfluoroalkyl Chemicals and Metabolic Disorders

To evaluate associations of longitudinal measures of exposure to perfluoroalkyl chemicals (PFCs) with detailed cardiometabolic risk measures.

  • Funding Partners: Harvard Medical School; Harvard Pilgrim Health Care Institute
  • Program Partners: CDC’s National Center for Environmental Health

> Perfluoroalkyl Chemicals and Metabolic Disorders

Perfluorocarbon Exposures in Urban Firefighters

To establish a reliable picture of the range, median tendency and predictors of perfluorocarbon (PFC) exposures in urban firefighters, and to establish how well the findings independently predict intermediate markers of cardiovascular and respiratory health.
  • Funding Partners: West Virginia University
  • Program Partners: CDC’s National Center for Environmental Health

> Perfluorocarbon Exposures in Urban Firefighters

Permethrin Exposure: Biomarkers and Dosimetry

To investigate determinants that significantly influence exposure to permethrin among military personnel, a critical step to provide valid predictive models and accurate policy guidance to mitigate any potential health risks associated from the use of permethrin-treated clothing.
  • Funding Partners: U.S Army Research Institute of Environmental Medicine
  • Program Partners: CDC’s National Center for Environmental Health

> Permethrin Exposure: Biomarkers and Dosimetry

Persistent Organic Pollutants and Cognitive Aging

To measure persistent organic pollutants (POPs) and provide data on the relation of POPs to accelerated cognitive aging.
  • Funding Partners: Rush Alzheimer’s Disease Center (National Institutes of Health)
  • Program Partners: CDC’s National Center for Environmental Health

> Persistent Organic Pollutants and Cognitive Aging

Pesticide Exposure in Migrant Farmworkers

To evaluate pesticide exposure in farmworkers as a function of heat stress and hydration levels in summer versus winter.
  • Funding Partners: University of Arizona
  • Program Partners: CDC’s National Center for Environmental Health

> Pesticide Exposure in Migrant Farmworkers

Phtalate, Sperm and Early Life Development

To investigate the association between paternal exposure to phthalates, sperm epigenetics and reproductive health.

  • Funding Partners: Brigham and Women's Hospital, Partners HealthCare System, Inc. (National Institutes of Health)
  • Program Partners: CDC’s National Center for Environmental Health

> Phtalate, Sperm and Early Life Development

Phthalate Biomarkers and Pregnancy Complications

To explore the relationship between maternal environmental chemical exposure and hormone levels at different stages of pregnancy.

  • Funding Partners: Brown University School of Public Health; Previous Partner: Women & Infants Hospital of Rhode Island
  • Program Partners: CDC’s National Center for Environmental Health

> Phthalate Biomarkers and Pregnancy Complications

Phthalate Exposure and Preeclampsia

To use the Combined Antioxidant and Preeclampsia Prediction Study (CAPPS) database and biospecimens to investigate the potential association between phthalate exposure and preeclampsia.
  • Funding Partners: Women & Infants Hospital of Rhode Island
  • Program Partners: CDC’s National Center for Environmental Health

> Phthalate Exposure and Preeclampsia

Phthalate Exposure in Adults

To evaluate the potential association between exposure to phthalates and the development of diabetes and obesity in adults.
  • Funding Partners: University of Illinois at Chicago, School of Public Health
  • Program Partners: CDC’s National Center for Environmental Health

> Phthalate Exposure in Adults

Phthalate Exposure in Pregnant Women Living in New York

To measure levels of phthalate metabolites in urine samples of pregnant women in New York City. 

  • Funding Partners: Columbia University
  • Program Partners: CDC's National Center for Environmental Health

> Phthalate Exposure in Pregnant Women Living in New York

Phthalate Exposure Testing

To test the prevailing hypothesis that exposure to phthalates is ubiquitous and to investigate if among populations with little exposure to commercial plastic and personal care products, phthalate metabolite concentration will be significantly lower than in western populations.

  • Funding Partners: Obstetrics and Gynecology, University of Rochester (University of Rochester Environmental Health Sciences Center; National Institute of Environmental Health Sciences / Eunice Kennedy Shriver National Institute of Child Health and Human Development; Women’s Health and the Environment over the Entire Lifespan)
  • Program Partners: CDC’s National Center for Environmental Health

> Phthalate Exposure Testing

Phthalates and Autism Spectrum Disorders Risk

To evaluate whether gestational exposure to phthalates is associated with an increased risk of autism spectrum disorders.
  • Funding Partners: University of California, Davis (National Institute of Environmental Health Sciences)
  • Program Partners: CDC’s National Center for Environmental Health

> Phthalates and Autism Spectrum Disorders Risk

Phthalates and Breast Cancer Risk

To evaluate whether exposure to phthalates is associated with breast cancer risk in a nested case-control study within the Women’s Health Initiative.
  • Funding Partners: University of Massachusetts Amherst
  • Program Partners: CDC’s National Center for Environmental Health

> Phthalates and Breast Cancer Risk

Phthalates and Diabetes Risk in Women

To investigate the potential association between phthalates and increased glucose dysregulation during pregnancy and postpartum period.
  • Funding Partners: Harvard Chan School of Public Health
  • Program Partners: CDC's National Center for Environmental Health

> Phthalates and Diabetes Risk in Women

Predictors of Mammary Gland Development

To assess the relation between putative early markers of breast cancer risk and exposure to endocrine-disrupting chemicals (EDCs), specifically phenols such as bisphenol A (BPA) and phthalates in urinary concentrations of select phenols and phthalate metabolites in a cohort of Chilean girls.

  • Funding Partners: Harvard University School of Public Health; Harvard University (Partners Healthcare System, Inc.)
  • Program Partners: CDC’s National Center for Environmental Health

> Predictors of Mammary Gland Development

Pregnancy and Endocrine Disruptors

To assess the feasibility of collecting urine and blood specimens from women who enroll in the Boston University PREgnancy Study Online program and to characterize the distribution of urinary bisphenol A (BPA) and phthalate-metabolites and serum-perfluorinated chemicals in collected urine and blood specimens.
  • Funding Partners: Slone Epidemiology Center at Boston University
  • Program Partners: CDC’s National Center for Environmental Health

> Pregnancy and Endocrine Disruptors

Pregnancy and Phthalates Exposure

To measure the levels of phthalates and their association with potential birth outcomes in a population of pregnant women living in Puerto Rico.
  • Funding Partners: University of Michigan School of Public Health
  • Program Partners: CDC's National Center for Environmental Health

> Pregnancy and Phthalates Exposure

Prenatal Exposure to Persistent Organic Pollutants

To measure persistent organic pollutants (POPs) and heavy metal concentrations in women in the third trimester of their pregnancy as proxy indicators of fetus exposure in the same period of time.
  • Funding Partners: National Institute of Public Health of Mexico
  • Program Partners: CDC’s National Center for Environmental Health

> Prenatal Exposure to Persistent Organic Pollutants

Role of Phthalates and Phenols in Autism Risk

To investigate the potential association between phthalates and environmental phenols as a risk factor for autism.

  • Funding Partners: Drexel University (National Institute of Environmental Health Sciences)
  • Program Partners: CDC’s National Center for Environmental Health

> Role of Phthalates and Phenols in Autism Risk

Role of Phthalates and Vitamin E in Diabetes Risk

To investigate the potential role of phthalates and Vitamin E in risk of diabetes.

  • Funding Partners: University of North Carolina at Chapel Hill Gillings School of Public Health
  • Program Partners: CDC’s National Center for Environmental Health

> Role of Phthalates and Vitamin E in Diabetes Risk

Semi-Volatile Organics Exposure in Children

To investigate the potential association between home exposure in children (ages 2-6) to semi-volatile organics and obesity.

  • Funding Partners: Duke University (National Institutes of Health)
  • Program Partners: CDC’s National Center for Environmental Health

> Semi-Volatile Organics Exposure in Children

Stanford Asthma Study

To determine biological mechanisms involved in Treg impairment resulting from PAH exposure and their effects on asthma.
  • Funding Partners: Stanford Medical Center; Lucile Packard Children’s Hospital
  • Program Partners: CDC’s National Center for Environmental Health

> Stanford Asthma Study

Temporal Variability-Urine Phenol During Pregnancy

To study the temporal variability of phenol urinary concentrations during pregnancy, focusing on the between-day and between-trimester variability. The study will identify the efficiency of within-subject pooling of biospecimens to characterize the mean urinary levels of phenols during pregnancy.
  • Funding Partners: Institut Albert Bonniot
  • Program Partners: CDC’s National Center for Environmental Health

> Temporal Variability-Urine Phenol During Pregnancy

Thyroid Cancer Risk Study

To investigate the relationship between polyhalogenated aromatic hydrocarbons (PHAHs) and thyroid hormones and the risk of thyroid cancer. This study will investigate whether the risk of thyroid cancer and thyroid hormone disruption associated with environmental exposure to PHAHs varies by genetic polymorphisms in major genes coding for enzymes involved in the regulation, metabolism or functional activities of PHAHs and endogenous thyroid hormones.
  • Funding Partners: Yale University School of Public Health
  • Program Partners: CDC’s National Center for Environmental Health

> Thyroid Cancer Risk Study

Tobacco Constituents in Female Menthol Smokers

To measure tobacco exposure biomarkers in female menthol smokers and to examine the potential impact of regulatory actions.
  • Funding Partners: University of Connecticut Health Center
  • Program Partners: CDC’s National Center for Environmental Health

> Tobacco Constituents in Female Menthol Smokers

Toxicants and Infant Male Reproductive Systems

To assess the effects of prenatal phthalate exposure on the developing male reproductive system. Anogenital distance will be used as a marker of exposure to reproductive toxicants and their effects. CDC’s Organic Analytical Toxicology Branch will provide biomonitoring data on phthalate metabolites in 786 urine samples collected prenatally from mothers who participated in the Infant Development and the Environment (TIDES) Study.

  • Funding Partners: Icahn School of Medicine at Mount Sinai
  • Program Partners: CDC’s National Center for Environmental Health

> Toxicants and Infant Male Reproductive Systems

Emergency Preparedness & Response

CDC is a key player in preparing the nation for large-scale public health emergencies—whether terrorist attacks, pandemic flu or natural disasters. CDC works with its partners at the national and local levels to develop and improve emergency preparedness plans that can be activated the moment disaster strikes. In addition, CDC experts are often among the first on the frontlines of a disaster, monitoring for potential disease outbreaks and assessing damage to healthcare infrastructures. The CDC Foundation has a number of funds and programs designed to support CDC's emergency preparedness and response activities.

Emergency Preparedness & Response Programs

Global Disaster Response Fund

To provide immediate, flexible resources to CDC experts, when their help is requested by health officials in another country to address a public health emergency—whether a natural disaster like the tsunami in Southeast Asia or the earthquake in Haiti or disease outbreak like Ebola. This fund is currently actvated for the Zika Response.

 

  • Funding Partners: Silicon Valley Community Foundation / Mark Zuckerberg and Dr. Priscilla Chan; Paul G. Allen Family Foundation; Robert Wood Johnson Foundation; Bill & Melinda Gates Foundation; HCA; Taiwan; Exxon Mobil; Alcoa Foundation; UPS; Henry Schein; BD (Becton, Dickinson and Company); Caring for Colorado; The Dayton Foundation; Charles F. Dillon Revocable Trust; GE Foundation; Hewlett Packard; Kaiser Permanente; Nelson Family Foundation; The Robert Wood Johnson Foundation; The UPS Foundation; multiple organizations and individuals
  • Program Partners: CDC's Office of Public Health Preparedness and Response; CDC's Center for Global Health

> Global Disaster Response Fund

U. S. Emergency Response Fund

The Emergency Response Fund helps CDC respond to public health emergencies and, when needed, allows CDC experts on the frontlines of an emergency to immediately purchase the specialized equipment or services needed to get the job done. This fund is currently activated for the Zika response.

  • Funding Partners: Bill & Melinda Gates Foundation; SC Johnson; Church & Dwight; RB; CRC Industries; 3M; Bayer; SC Group; multiple organizations and individuals; Previous Funding Partners: IBM; Kaiser Permanente; Preparis Inc.; Robert Wood Johnson Foundation; T-Mobile USA, Inc.
  • Program Partners: CDC's Office of Public Health Preparedness and Response

> U. S. Emergency Response Fund

Occupational Health & Safety

CDC's National Institute for Occupational Safety and Health (NIOSH) is the federal agency responsible for conducting research and making recommendations for the prevention of work-related injury and illness. NIOSH gathers information, conducts scientific research, and translates the knowledge gained into products and services, including scientific information products, training videos and recommendations for improving safety and health in the workplace.The CDC Foundation helps NIOSH collaborate with industry leaders, employers and research institutions to advance learning and effectively address occupational health threats.

Occupational Health & Safety Programs

Assessment of Occupational Fall Hazards

To improve worker safety while using mast climbing work platforms.

  • Funding Partners: Job-Site Safety Institute
  • Program Partners: CDC's National Institute for Occupational Safety and Health

> Assessment of Occupational Fall Hazards

Cardiovascular and Carcinogenic Risks in Training Scenarios

To conduct a study to assess firefighters’ cardiovascular and carcinogenic risks during training scenarios.

  • Funding Partners: University of Illinois
  • Program Partners: CDC's National Institute for Occupational Safety and Health (NIOSH)

> Cardiovascular and Carcinogenic Risks in Training Scenarios

Cleaning Procedures for Fire Fighter PPE

To establish clear guidance for applying cleaning and decontamination procedures that effectively remove both chemical and biological contaminants from fire fighter personal protective equipment (PPE).

  • Funding Partners: Fire Protection Research Foundation
  • Program Partners: CDC’s National Institute for Occupational Safety and Health

> Cleaning Procedures for Fire Fighter PPE

Reproductive Health Issues and Exposure to PBBs

To measure polybrominated biphenyls (PBBs) and determine the extent of endocrine disruption resulting from exposure to these compounds.

  • Funding Partners: Emory University (National Institutes of Health)
  • Program Partners: CDC's National Institute for Occupational Safety and Health

> Reproductive Health Issues and Exposure to PBBs

Thomas R. Waters Memorial Scholarship for Ergonomics Research

To increase the community of individuals trained in ergonomics with a focus on occupational safety and health. Established in 2015, this fund honors the memory of Thomas R. Waters, who retired from CDC's National Institute for Occupational Safety and Health at the end of 2012 after a distinguished 24-year career in the field of occupational safety and health, and who passed away suddenly in October 2014.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC’s National Institute for Occupational Safety and Health (NIOSH)

> Thomas R. Waters Memorial Scholarship for Ergonomics Research

Time to Conceive and Biomarkers of Infertility

To assess the reproductive potential of women exposed to occupational hazards.

  • Funding Partners: University of North Carolina at Chapel Hill
  • Program Partners: CDC's National Institute for Occupational Safety and Health

> Time to Conceive and Biomarkers of Infertility

Public Health Leadership

The CDC Foundation recognizes individuals who make significant contributions to improving health and supports learning experiences to inspire future generations of public health leaders. Many of the awards are made possible by contributions from individuals and organizations to a CDC Foundation endowment or restricted fund.

 

Public Health Leadership Programs

CDC Experience Legacy Project

To enhance development of health professionals by providing them tools to expand their competency to improve community and population health in a changing health system.

  • Funding Partners: Pfizer Inc.
  • Program Partners: CDC’s Center for Surveillance, Epidemiology and Laboratory Services

> CDC Experience Legacy Project

CDC-Hubert Global Health Fellowship

To provide an opportunity for third- and fourth-year medical and veterinary students to gain public health experience in an international setting. Hubert fellows spend six to twelve weeks in a developing country working on a priority health problem in conjunction with CDC staff.

  • Funding Partners: O.C. Hubert Charitable Trust, Pfizer
  • Program Partners: CDC's Office of Surveillance, Epidemiology and Laboratory Services

> CDC-Hubert Global Health Fellowship

David J. Sencer CDC Museum

To serve as CDC’s gateway to the public, the David J. Sencer CDC Museum is dedicated to comprehensive scientific learning and outreach. Composed of innovative permanent exhibits representing the breadth of CDC’s work and history, topical changing exhibits, a theater and a classroom, this facility serves to educate all who visit about public health and the important work of CDC, with a special emphasis on curriculum-based educational workshops and camps targeting middle- and high-school students.

  • Funding Partners: Multiple organizations
  • Program Partners: CDC's Office of Associate Director for Communication

> David J. Sencer CDC Museum

David J. Sencer CDC Museum: Places and Spaces: Mapping Science

To present a temporary exhibition at the David J. Sencer CDC Museum that includes state-of-the-art visualization of scientific data. This exhibit will demonstrate how data visualization is linked to public health and the work of CDC.

  • Funding Partners: Thomson Reuters
  • Program Partners: CDC’s Office of the Associate Director for Communication; CDC's Office of Public Health Scientific Services Office

> David J. Sencer CDC Museum: Places and Spaces: Mapping Science

David J. Sencer EIS Alumni Association Scholarship Fund

To provide travel scholarships to potential Epidemic Intelligence Service (EIS) IS applicants to attend the EIS Conference.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: EIS Alumni Association

> David J. Sencer EIS Alumni Association Scholarship Fund

Donald C. Mackel Award

To recognize the best collaborative work between epidemiology and laboratory scientists presented at the annual EIS Conference.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: EIS Alumni Association

> Donald C. Mackel Award

Dr. Michael T. and Gloria Melneck Fund for Oral Health Promotion Endowment Fund

To help improve oral health promotion in the field of public health with a special emphasis on preventive and pediatric dental health.

  • Funding Partners: Michael Melneck
  • Program Partners: CDC's Office of Noncommunicable Diseases, Injury and Environmental Health

> Dr. Michael T. and Gloria Melneck Fund for Oral Health Promotion Endowment Fund

EIS 50th Anniversary Fellowship

To provide stipends to MD/MPH or PhD students from the Rollins School of Public Health at Emory who are selected to participate in the CDC Elective Rotation in Applied Epidemiology.

  • Funding Partners: O.C. Hubert Charitable Trust
  • Program Partners: CDC’s National Center for Surveillance, Epidemiology and Laboratory Services

> EIS 50th Anniversary Fellowship

Epidemic Intelligence Service Fund

To support the Epidemic Intelligence Service Alumni Association in their efforts to educate future disease detectives. 

  • Funding Partners: Epidemic Intelligence Service Alumni Association (EISAA); multiple individuals and organizations
  • Program Partners: Epidemic Intelligence Service Alumni Association (EISAA)

> Epidemic Intelligence Service Fund

Fries Prize for Improving Health

To recognize an individual who has made major accomplishments in health improvement with emphasis on recent contributions to health in the United States, and with the general criteria of the greatest good for the greatest number.
  • Funding Partners: James F. and Sarah T. Fries Foundation
  • Program Partners: CDC Foundation

> Fries Prize for Improving Health

Gerald R. Cooper Laboratory Safety Award

To give an annual award to a CDC employee in recognition of important contributions to laboratory safety.

  • Funding Partners: Established by Batelle with support from The Columbus Foundation
  • Program Partners: CDC’s Office of the Director

> Gerald R. Cooper Laboratory Safety Award

Iain R.B. Hardy, M.D., EIS '92 Memorial Award

To honor an EIS officer or recent graduate (within five years) for contributions to vaccine-preventable diseases.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC's Epidemic Intelligence Service

> Iain R.B. Hardy, M.D., EIS '92 Memorial Award

Improving Population Health in California

To increase private-sector understanding of the role of CDC in population-based health and to build partnerships that advance public health in California and nationally.
  • Funding Partners: The California Endowment
  • Program Partners: CDC’s Office of the Director

> Improving Population Health in California

James Buffington Jr. and Lois Chapman Buffington Endowment for the Alexander D. Langmuir Prize

To honor a current or former EIS Officer (within one year of graduation) for the best scientific manuscript submitted to the EISAA Executive Committee for review.

  • Funding Partners: Established by Joanna Buffington, M.D., EIS '90 and supported by multiple individuals
  • Program Partners: EIS Alumni Association

> James Buffington Jr. and Lois Chapman Buffington Endowment for the Alexander D. Langmuir Prize

James H. Steele, D.V.M., EIS '75 Veterinary Public Health Award

To recognize current or former EIS Officers (within five years of having completed EIS training) who have made outstanding contributions in the field of veterinary public health.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: EIS Alumni Association

> James H. Steele, D.V.M., EIS '75 Veterinary Public Health Award

Jeryl Lynn Hilleman Endowed Lectureship

To honor CDC’s 50th anniversary and the 25th anniversary of the first combination vaccine for measles, mumps and rubella, this award funds an annual lecture at CDC’s National Immunization Conference by an individual whose work or leadership has made significant contributions to the elimination of measles, mumps, or rubella.

  • Funding Partners: Established by the Merck Company Foundation and supported by multiple individuals and organizations
  • Program Partners: CDC’s National Center for Immunization and Respiratory Diseases

> Jeryl Lynn Hilleman Endowed Lectureship

Jonathan M. Mann Memorial Lecture Fund

To honor the career of the late Dr. Jonathan M. Mann, this fund supports a lecture administered by the Council of State and Territorial Epidemiologists during their annual conference.

  • Funding Partners: Richard E. Hoffman, MD, EIS '78
  • Program Partners: CDC Foundation

> Jonathan M. Mann Memorial Lecture Fund

Linda Saltzman New Investigator Award

To recognize an outstanding new investigator with 2-10 years of experience working in the field of domestic violence, violence against women or dating violence. Futures Without Violence, CDC and a committee of experts selects an outstanding individual to receive the award every other year beginning 2012. The recipient receives passage to the National Conference on Health and Domestic Violence.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC's National Center for Injury Prevention and Control

> Linda Saltzman New Investigator Award

Marge and Bill Watson Endowment for the William C. Watson Jr. Medal of Excellence

To provide an annual service award to a CDC employee for outstanding achievements. The CDC Medal of Excellence was established in 1977 as the premiere service award for CDC employees and was renamed for William Watson in 1985 on the occasion of his retirement from CDC. In 1999, Marge and William Watson established the Watson Endowment, which provides permanent funding for a cash award to be given by the Foundation to recipients of the Watson Medal of Excellence each year.

  • Funding Partners: Established by Marge and Bill Watson and supported by multiple individuals and organizations
  • Program Partners: CDC

> Marge and Bill Watson Endowment for the William C. Watson Jr. Medal of Excellence

Pappaioanou Veterinary Public Health and Applied Epidemiology Fellowship

To provide competitively selected veterinarians and 3rd and 4th year veterinary medical students with opportunities in an applied hands-on training experience in epidemiology, public health or global health. Each fellow will spend up to one full year at CDC working on a U.S.-focused or global public health project.

  • Funding Partners: Marguerite Pappaioanou, D.V.M., M.P.V.M., Ph.D., D.A.C.V.P.M.; multiple individuals and organizations
  • Program Partners: CDC

> Pappaioanou Veterinary Public Health and Applied Epidemiology Fellowship

Paul C. Schnitker, M.D., EIS '69 Endowed Memorial Award for Global Public Health

To recognize a current EIS Officer at CDC or a first-year EIS alumnus/a who has made an unusual contribution to global public health.

  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC's Epidemic Intelligence Service

> Paul C. Schnitker, M.D., EIS '69 Endowed Memorial Award for Global Public Health

Public Health Prevention Service Alumni Association

To provide support for the Public Health Prevention Service Alumni Association by maintaining a national network of public health professionals.

  • Funding Partners: Public Health Prevention Service Alumni
  • Program Partners: Public Health Prevention Service Alumni

> Public Health Prevention Service Alumni Association

Strengthening the EIS Alumni Association

To strengthen the Epidemic Intelligence Service (EIS) Alumni Association (EISAA) and support the EIS Program. In an era of challenging public health priorities and fewer resources, a growing concern of CDC and the EISAA is ensuring program support in areas in which CDC and government financial and human resources are reduced. The EISAA proposes to strengthen the Alumni Association to ensure its vision, organization, and resources are oriented to support the alumni network and the EIS Program at CDC.

  • Funding Partners: de Beaumont Foundation
  • Program Partners: CDC’s Center for Surveillance, Epidemiology, and Laboratory Services; Epidemic Intelligence Service Alumni Association (EISAA)

> Strengthening the EIS Alumni Association

The Elizabeth Fries Health Education Award

To recognize a health educator who has made a substantial contribution to advancing the field of health education or health promotion through research, program development or program delivery.

  • Funding Partners: James F. and Sarah T. Fries Foundation
  • Program Partners: CDC Foundation

> The Elizabeth Fries Health Education Award

Thomas A. Bartenfeld III Award for Public Health Practice

To recognize an individual each year who reflects excellence in public health practice—a rare combination of perspective grounded in frontline, day-to-day public health work and constant drive toward meaningful program measurement and outcomes.
  • Funding Partners: Multiple individuals and organizations
  • Program Partners: CDC

> Thomas A. Bartenfeld III Award for Public Health Practice